office of research and graduate studies stafffile.cop.ufl.edu/millard/annual_reports/ar1112.pdf ·...

ii

Office of Research and Graduate Studies Staff

William J. Millard, Ph.D.

Executive Associate Dean

Professor, Department of Pharmacodynamics

Gary Hamlin

Sr. Grants Specialist

Deborah Bambarola

Grants Specialist

José Ortiz

Office Assistant

iii

Table of Contents

Section Page

Introduction .............................................................................................................................................................. 1

Graduate Education and Program Activities ........................................................................................................ 2

Graduate Programs in the College ........................................................................................................................ 2

Graduate Studies Committee Activities ................................................................................................................ 3

College of Pharmacy Graduate Student Organization ........................................................................................... 3

Graduate Faculty, Graduate Student, Post-doctoral Fellow, Visiting Scholar

and Exchange Student Demographics .............................................................................................................. 4

PharmD/Ph.D. Students in Graduate Programs in the College of Pharmacy ........................................................ 8

FDA/CDER Students in the Master’s Program ..................................................................................................... 9

Graduate Student Recruitment Activities .............................................................................................................. 9

Exchange Students in the College of Pharmacy .................................................................................................... 9

Graduate Student Graduation Activities ............................................................................................................... 10

Graduate Student Funding and Awards ................................................................................................................. 16

Graduate Minority Activities ................................................................................................................................ 19

Research Activities in the College of Pharmacy .................................................................................................... 20

Grant and Contract Efforts and Funding ............................................................................................................... 20

Clinical Laboratories Income ................................................................................................................................ 25

Licensing and Royalty Income .............................................................................................................................. 25

Graduate Student Research Activities and Awards ............................................................................................... 25

Professional Student Research Activities and Awards .......................................................................................... 26

U.S.-Thai Consortium Activities ............................................................................................................................. 28

History of the U.S.-Thai Consortium. ................................................................................................................... 28

11th

U.S.-Thai Pharmacy Education Consortium Meeting .................................................................................... 28

ORGS Coordinated Events...................................................................................................................................... 30

Post-baccalaureate Reception ............................................................................................................................... 30

Annual Research Showcase and Awards Recognition Day ................................................................................... 30

Other ORGS Activities ............................................................................................................................................ 32

Committee Assignments........................................................................................................................................ 32

Conferences Attended Related to ORGS Activity ................................................................................................ 33

Appendices ................................................................................................................................................................ 34

A= Letter to Graduate Applicants ......................................................................................................................... 35

B= Complete Listing of Extramural Support by Department and Faculty ............................................................ 37

C= 25th

Annual Research Showcase and Awards Recognition Day Booklet ........................................................ 43

1

Introduction

The Office of Research and Graduate Studies (ORGS) was established in the College of Pharmacy (COP) in 1989 as the

major unit within the College responsible for the oversight of all aspects of the graduate programs (M.S. and Ph.D.) as well as

research activities. Within the purview of these two major activities are a number of functions that are coordinated by ORGS

personnel and make up the daily operations of the office.

The structure of the ORGS is outlined in Figure 1. Dr. William J. Millard, Professor in the Department of

Pharmacodynamics, accepted the role as Associate Dean for Research and Graduate Studies on an acting basis in January 1995,

and then on a permanent basis in August 1997. On January 1, 1999, Dr. Millard accepted the permanent position as Executive

Associate Dean for the College of Pharmacy and as part of this position maintains oversight of the ORGS and reports all ORGS

activities directly to the Dean of the College.

Graduate Coordinator, Pharmacodynamics

Joanna Peris, Ph.D.

Graduate Coordinator, Pharmaceutics

Tony Palmieri, R.Ph., Ph.D.

Graduate Coordinator, Medicinal Chemistry

Raymond Bergeron, Ph.D.

Graduate Coordinator, Pharmaceutical

Outcomes and Policy

Almut Winterstein, Ph.D.

Graduate Coordinator, Pharmacotherapy &

Translational Research

Reginald Frye, PharmD, Ph.D.

Executive Associate Dean

William J. Millard, Ph.D.

Sr. Grants Specialist

Gary Hamlin

Dean, College of

Pharmacy

William H. Riffee, R.Ph.,

Ph.D.

Figure 1: Administrative Flow Chart for the ORGS

Director, Forensics Sciences Program

Ian Tebbett, Ph.D.

Grants Specialist

Deborah Bambarola

Office Assistant

Jose Ortiz

The Executive Associate Dean is responsible for monitoring all graduate student applications, quality of graduate students

and the progression of students through the graduate programs in the College. The Executive Associate Dean's role also

includes monitoring of the quality of graduate programs and seeking ways to expand or improve graduate education within the

COP. The Executive Associate Dean also acts as the major liaison between the Graduate School and the Office of Research,

Technology and Graduate Education (ORTGE) at the University of Florida and the COP faculty and graduate students.

Information concerning graduate programs and education within the COP is communicated from the Executive Associate

Dean to faculty or graduate students through the Departmental Chairs and Graduate Coordinators. This year the college had

two changes in graduate coordinators during the academic year. Dr. Taimour Langaee assumed the graduate coordinator role in

Pharmacotherapy & Translational Research in January 2012 owing to Dr. Reginald Frye assuming the Department Chairs

position. In March 2012 owing to the retirement of Dr. Raymond Bergeron, Dr. Hendrik Luesch assumed the graduate

coordinator position in Medicinal Chemistry. The Graduate Studies Committee and COP Graduate Student Organization assist

the Executive Associate Dean in the responsibility of governing graduate education in the COP (see: Graduate Education and

Program Activities, Graduate Studies Committee Activities, College of Pharmacy Graduate Student Organization).

Related to research activities, the Executive Associate Dean has the major responsibility to see that faculty remain active in

their individual research programs and to assist them in the grant or contract submission process. It is the Executive Associate

Dean’s responsibility to ensure that all grants are submitted and logged through UF in the proper manner. This includes making

sure that proper contractual arrangements and documentation are completed and that each contract or grant contain the proper

faculty percent effort and salary offset dollars, as well as correct Facilities & Administrative (F&A) cost and graduate student

support. The Executive Associate Dean also sees that information relevant to research is communicated to the proper faculty or

personnel within the COP.

The Executive Associate Dean is assisted in the ORGS by three staff members; a Sr. Grants Specialist, a Grants Specialist

and an Office Assistant. In January 2011 a Sr. Grants Specialist position was created and filled by Mr. Gary Hamlin. Since

June 2001, the Grants Specialist has been Ms. Deborah Bambarola. In July 2011, Mr. José Ortiz started to assume some of the

responsibilities related to the graduate duties as the Office Assistant. These three positions work together to handle the daily

operations of the ORGS. Some of these duties include the tracking and reporting of graduate information and students, assisting

students with various problems and graduate course registration, submission of needed reports to the COP, University and

outside agencies, the coordination of the various functions of the ORGS, as well as the tracking and filing of new research

grants and the monitoring of post-award activities.

The remainder of this report will deal with COP Graduate Programs, COP Research Activity, U.S.-Thai Consortium

Activities, Coordinated Functions and Other Activities of the ORGS.

2

Graduate Education and Program Activities

Graduate Programs in the College of Pharmacy

The College of Pharmacy offers both residential and online graduate programs. There is only one residential Ph.D.

program administered through the College: Ph.D. in Pharmaceutical Sciences. Under the umbrella of the Ph.D. in

Pharmaceutical Sciences (established in 1932) there are four graduate specialty programs that are recognized in the College of

Pharmacy by the Graduate School. These graduate specialties are: Medicinal Chemistry (recognized in 1978),

Pharmacodynamics (recognized in 1989), Pharmaceutical Outcomes and Policy (recognized in 1996), and Pharmaceutics

(recognized in 1998).

In February, the Department of Pharmacotherapy & Translational Research received approval from the Graduate School

for their stand-alone graduate concentration in “Clinical Pharmaceutical Science”. This new concentration will be effective in

the Fall 2012 Semester. This concentration was initiated in 2004 when faculty within the Department saw that there was a

critical need for clinically-trained professionals to have rigorous research training in order to facilitate and grow translational

research in the Pharmaceutical and Biomedical Sciences. This is a major milestone in our College as now each Department has

their own graduate concentration under the Pharmaceutical Sciences umbrella. Tied to each of the residential Ph.D. programs

in the College is an associated Master of Science (M.S.) in the Pharmacy Program. The M.S. in Pharmacy in the Departments

of Medicinal Chemistry, Pharmaceutics, and Pharmacodynamics requires each student to prepare and defend a thesis as part of

their degree. Pharmaceutical Outcomes and Policy and Pharmacotherapy & Translational Research have the option of a thesis

or non-thesis M.S. degree. In general, residential graduate students are discouraged from entering directly into an M.S. in

Pharmacy; instead, students are strongly encouraged to enter into one of the Ph.D. programs. However, students may opt for

the M.S. degree in their discipline if they find that the Ph.D. degree is not what they desire after entering the program.

The U.S. Food and Drug Administration/Center for Drug Evaluation and Research (FDA/CDER) in collaboration with the

University of Florida, offered a residential educational program aimed at attracting scientists and health professionals to the

FDA/CDER. Due to federal budgetary reductions to the FDA, this program has been temporarily discontinued. This UF/FDA

Graduate Program provided participants with two years of advanced graduate education at the Masters (M.S.) or Doctorate

(Ph.D.) level designed to advance scientific training and analysis involved in the safety and regulatory decisions unique to the

center’s and agency’s mission. This program graduated its second cohort resulting in a total of 15 students who have

successfully completed the program. Graduating students serve an assignment at the FDA/CDER for at least four years after

graduation. One student graduating with a M.S. degree from the second cohort is continuing his Ph.D. studies in the

Department of Pharmaceutical Outcomes and Policy .

The College also offers a number of online programs leading to the M.S. degree. The University of Florida online

Forensic Science Program has grown to become the largest graduate forensic program in the world with almost seven hundred

enrollments each semester from some 40 different countries. Designed to meet the needs of working professionals, the program

consists of four areas of concentration: Forensic Toxicology, Forensic Drug Chemistry, Forensic DNA & Serology and

Forensic Science. Within each concentration the program offers a Master’s Degree or a Certificate. The Toxicology

concentration is provided by the College of Veterinary Medicine while the Drug Chemistry, DNA & Serology, and Forensic

Science concentrations are provided by the College of Pharmacy. The program has received national recognition for excellence

by the American Distance Education Consortium and the U.S. Distance Learning Association.

Sister programs in Pharmaceutical Chemistry and Clinical Toxicology were introduced in 2009 and 2011 respectively. The

Pharmaceutical Chemistry program is primarily designed for those already employed, or seeking employment, in the

pharmaceutical industry, while the Clinical Toxicology program appeals to emergency room and poison control center staff.

In FY 05/06, the Department of Pharmaceutical Outcomes and Policy initiated an online Master's program that provides

the necessary expertise and credentials to understand and apply issues relating to regulatory policies and law, and to serve as an

authoritative source in the workplace on regulatory matters. Because the program is open to students from all academic and

professional backgrounds (PharmD not required), this unique Master's program serves as a career pathway for people both

inside and outside the pharmacy industry to pursue careers with pharmaceutical companies, governmental agencies,

professional associations, managed care and research organizations, benefits management companies, health systems and

industry. The Master of Science in Pharmacy, with concentration in Pharmaceutical Outcomes and Policy, offers several

specialty tracks: Pharmacy Regulation & Policy, Applied Pharmacoeconomics, Clinical Research Regulation in Pharmacy,

Patient Safety & Medication Risk Management, Drug Regulatory Affairs, and Institutional Pharmacy Leadership. Courses for

this 30-credit program are held online in highly-interactive, live, virtual classrooms, and students are required to attend two or

three weekend seminars and to take a final comprehensive exam on campus. Currently, the program has approximately 172

enrolled students and 196 alumni.

The newest online Master’s program in the College is the Master of Science in Pharmacy with concentration in

Medication Therapy Management (MS-MTM). The MS-MTM program is a 33-credit degree program designed for working

pharmacists who wish to continue their career while gaining innovative patient care and business skills needed to become a

leader in the groundbreaking field of medication therapy management. The online program can be completed in as little as five

http://www.cop.ufl.edu/departments/PHCA/Newsite/Graduatestudies/Prospectivestudents/popmasters.htm

http://www.cop.ufl.edu/departments/PHCA/Newsite/Graduatestudies/Prospectivestudents/popmasters.htm

http://www.forensicscience.ufl.edu/

http://pharmreg.dce.ufl.edu/index.html

http://www.cop.ufl.edu/education/graduate-programs/interdisciplinary-online-graduate-programs/msmtm/

3

semesters and requires at least one visit to the main campus for a week-long live seminar. The MS-MTM program currently has

59 students enrolled, and the first cohort will graduate in Fall 2012.

Graduate Studies Committee (GSC) Activities

During FY 91/92 all Graduate Studies/Programs were decentralized in the College from the ORGS and into each of the

individual departments. With this decentralization the review or setting of graduate policies and graduate student recruitment

is now in the hands of the individual departments. To assist the ORGS in the management of graduate activities in the College,

the Graduate Studies Committee (GSC) was established.

The primary goal for the GSC is to be a medium through which graduate and research programmatic goals are reviewed on

a continual basis and aligned with the goals of the College and the University (i.e., continuous quality improvement, CQI).

The primary charge of the GSC is to review and make recommendations on graduate programs in the College of Pharmacy.

This would include both new and existing graduate programs. The GSC is involved in considering how the College can

attract/fund more graduate students with an emphasis on bringing in more U.S. students and professional (pharmacy) students.

This committee is also involved in reviewing any future major mandate(s) from the Graduate School that may impact the

functioning of the overall graduate program within the College (i.e., stipends; tuition waivers). The committee continues to

select finalists in the College’s Spring Research Competition and also makes recommendations on how to improve this College

function.

The makeup of the GSC includes a graduate coordinator representative from each of the departments and the

President of the COP Graduate Student Organization. The Executive Associate Dean serves as the non-voting chair, and

the Dean as ex-officio member of the committee. The Office Assistant sits in on all committee meetings as the recording

secretary. Representatives on the Committee were:

Non-voting Chair: Dr. William Millard Office of Research and Graduate Studies

Voting Members: Drs. Raymond Bergeron & Hendrik Luesch Medicinal Chemistry

Dr. Joanna Peris Pharmacodynamics

Dr. Almut Winterstein Pharmaceutical Outcomes and Policy

Dr. Tony Palmieri Pharmaceutics

Drs. Reginald Frye & Taimour Langaee Pharmacotherapy & Translational Research

Dr. Ian Tebbett Forensic Science Program

Mr. Jonathan Schelfhout President of COP Graduate Student Organization

Ex-officio Member: Dr. William Riffee Dean

The GSC met ten times throughout the year. Some of the issues that were deliberated included:

Selection of the FY 12/13 Graduate School Fellowship Awardees

Review of the use of Liberty Award monies for graduate students in each of the departments

Use of State Line OPS monies for graduate student stipends

Establishment of TA assignments for each of the semesters

Continual review of graduate programs in each deparment

Establishment of goals and objectives for each graduate program within the College

Selection of finalists for the 25th

Annual Research Showcase and Awards Recognition Day

College of Pharmacy Graduate Student Organization

The COP Graduate Student Organization (GSO) is an avenue by which graduate students can discuss common issues

related to graduate education and bring their concerns to the attention of the Executive Associate Dean for Research and

Graduate Studies. The COP GSO elects a president on an annual basis. The president of the organization coordinates and runs

the meetings (1-2 per year) and also sits in on the Graduate Studies Committee as a voice for the graduate students. Mr.

Jonathan Schelfhout, from the Department of Pharmaceutical Outcomes and Policy, served as president of the organization.

At the beginning of each Fall semester, the ORGS sponsors a luncheon for COP graduate students to promote a forum for

exchange of information between each other and the ORGS.

4

Graduate Faculty, Graduate Student, Post-doctoral Fellow, Visiting Scholar and Exchange Student

Demographics

The College has 55 graduate faculty members who are closely involved in the training of all graduate students, post-

doctoral fellows and visiting students and scholars. A complete listing of the college graduate faculty, by department, can be

found in Table 1. The COP accepted 12 new students into the various Graduate Programs. A listing of all residential

graduate students according to their department with their date of entrance into the graduate program, degree sought and

mentor is found in Table 2. Ninety-three graduate students were engaged in residential studies leading to either the M.S. or

Ph.D. degree this year. The COP graduated 14 Ph.D. students and 11 M.S. students (see: Graduate Student Graduation

Activities). In addition, 851 graduate students were pursuing a M.S. degree program by online education. Noteworthy, is that

159 (18.7%) of these students graduated this past academic year.

Table 3 outlines the overall demographics of the residential graduate student population within the COP. This year the

number of male students compared to female students was a 41/59 percent male/female ratio. The college has a 39/61 percent

American/Foreign student ratio as well. The percent of U.S. minority students was 9.7% (9 of 93) for FY 11/12. This is an

increase from the previous year of 6.7% (6 of 89). Distribution of graduate students among the departments is illustrated in

Table 4. This year the Department of Pharmaceutical Outcomes and Policy had the highest number of students with 29;

Pharmaceutics had 25; Medicinal Chemistry and Pharmacodynamics both had 14; and Pharmacotherapy & Translational

Research had 11 students pursuing graduate degrees. GPA and graduate program entrance test scores for both the entire

population of the residential graduate students and the entering class of 11/12 are shown in Table 5.

For the sake of completeness, a listing by department of Post-doctoral Fellows and Visiting Scholars in the COP is

illustrated in Table 6 and a listing of Exchange Students is listed in Table 10. Noteworthy is that the COP Ph.D./M.S.

graduate program had 1 student from Pharmaceutical Outcomes and Policy leave the graduate program during FY 11/12.

Table 1: Graduate Faculty

Department/Center Faculty Name

Medicinal Chemistry Raymond Bergeron Hendrik Luesch

Raymond Booth Kenneth Sloan

Oliver Grundmann Ian Tebbett

Margaret James Donna Wielbo

Pharmaceutics/Center for Nicholas Bodor Sven Normann

Drug Discovery & Center Veronika Butterweck Tony Palmieri

for Drug Interaction Hartmut Derendorf Stephan Schmidt

Research and Education Guenther Hochhaus Sihong Song

Cary Mobley

Pharmacodynamics Dorette Ellis Bin Liu

Jason Frazier Michael Meldrum

Carrie Haskell-Luevano William Millard

Michael Katovich Joanna Peris

Eric Krause William Riffee

Maureen Keller-Wood

Pharmaceutical Outcomes and Diane Beck Earlene Lipowski

Policy/Center for Research David Brushwood Folakemi Odedina

in Pharmaceutical Care Joseph Chris Delaney Richard Segal

Abraham Hartzema Thomas Smith

Teresa Kauf Burcin Unel

Carole Kimberlin Almut Winterstein

Pharmacotherapy & Translational Research/ Rhonda Cooper-DeHoff Larry Lopez

Center for Pharmacogenomics Abdolreza Davoodi-Semiromi John Markowitz

Paul Doering Michael McKenzie

Reginald Frye Charles Peloquin

Leslie Hendeles Karen Whalen

Julie Johnson Yan Whisler

Taimour Langaee Haojie Zhu

5

Table 2: Graduate Students in Residential Programs

Department/Center Name Date Expected Degree

Mentor Entered Grad Date Sought

Medicinal Chemistry Ambadapadi, Sriram Aug. 07 May. 13 Ph.D. James

Bousquet, Michelle Aug. 10 Aug. 14 Ph.D. Luesch

Felsing, Daniel * Aug. 11 May. 15 Ph.D. Booth

Jackson, Erin Aug. 10 Aug. 14 Ph.D. James

Kondabolu, Krishnakanth Aug. 08 May. 13 Ph.D. Booth

Merritt, Kristen ** Aug. 02 Aug. 11 Ph.D. James

Metavarayuth, Kamolrat Aug. 10 Aug. 12 M.S. Luesch

Montaser, Rana Aug. 08 Aug. 13 Ph.D. Luesch

Salvador, Lilibeth Aug. 08 Aug. 13 Ph.D. Luesch

Synovec, Jennifer Aug. 09 May. 13 Ph.D. Sloan

Thiele, Nikki * Aug. 11 May. 16 Ph.D. Sloan

Travers, Sean ** Aug. 06 Aug. 11 Ph.D. Booth

Wang, Rui Aug. 07 Dec. 12 Ph.D. Luesch

Zhong, Guo * Aug. 11 May. 16 Ph.D. James

Pharmaceutics Akbar, Mohammad Jan. 10 Dec. 14 Ph.D. Song

Alalaiwe, Ahmed Aug. 10 Aug. 14 Ph.D. Frye

Albassam, Ahmed Aug. 10 Aug. 14 Ph.D. Hochhaus

Barth, Aline Aug. 10 Aug. 14 Ph.D. Derendorf

Bhagwat, Sharvari * Aug. 11 May. 15 Ph.D. Hochhaus

Chen, Guanming * Aug. 11 May. 15 Ph.D. Song

Chen, Mongjen Aug. 09 May. 13 Ph.D. Song

Conrado, Daniela Jan. 09 Dec. 13 Ph.D. Derendorf

Fueth, Matthias ** Aug. 07 Dec. 11 Ph.D. Song

Hassan, Am Mahbub Aug. 05 Dec. 12 Ph.D. Hochhaus

Haug, Karin Jan. 09 Dec. 13 Ph.D. Butterweck

Kandala, Bhargava Aug. 09 May. 13 Ph.D. Hochhaus

Le, Huong ** Aug. 07 May. 12 Ph.D. Song

Li, Li Jan. 09 Dec. 13 Ph.D. Butterweck

Liu, Xuan Aug. 09 May. 13 Ph.D. Butterweck

Naik, Runa ** Aug. 07 Aug. 11 Ph.D. Derendorf

Song, Xuyang June. 09 May. 13 Ph.D. Derendorf

Sun, Wan Aug. 08 May. 13 Ph.D. Derendorf

Sy, Sherwin Aug. 10 Aug. 14 Ph.D. Derendorf

Tatipali, Manasa Jan. 10 May. 14 M.S. Palmieri

Vieira, Manuela ** Aug. 07 Aug. 11 Ph.D. Derendorf

Waters, Chad Jan. 09 May. 13 Ph.D. Palmieri

Weber, Benjamin Jan. 09 Dec. 13 Ph.D. Hochhaus

Zhou, Di Jan. 11 Dec. 15 Ph.D. Hochhaus

Zhuang, Luning * Jan. 11 Dec. 15 Ph.D. Derendorf

Clinical Pharmaceutical Chang, Shin-Wen * Aug. 11 May. 15 Ph.D. Cooper-DeHoff

Science: Davis, Heather ** Aug. 07 May. 12 Ph.D. Johnson

Pharmacotherapy & Egelund, Eric Aug. 09 May. 13 Ph.D. Peloquin

Translational Research Gonzalez, Daniel Aug. 08 May. 13 Ph.D. Derendorf

Jabarti, Hanaa * Aug. 11 May. 15 Ph.D. Hendeles

Karnes, Jason Aug. 08 May. 13 Ph.D. Cooper-DeHoff

Kawaguchi, Marina Aug. 10 May. 14 Ph.D. Frye

Moore, Mariellen Aug. 07 Dec. 12 Ph.D. Johnson

6

Table 2: Graduate Students in Residential Programs (cont.)

Department/Center Name Date Expected Degree

Mentor Entered Grad Date Sought

Pharmacotherapy & Shahin, Mohamed * Aug. 11 May. 15 Ph.D. Johnson

Translational Research Stanton, Melonie ** Aug. 06 May. 12 Ph.D. Frye

(cont.) Sultan, Abdullah * Aug. 11 May. 15 Ph.D. Peloquin

Pharmaceutical Outcomes Ali, Ayad Aug. 05 Dec. 12 Ph.D. Hartzema

and Policy Bird, Steven ** Aug. 10 May. 12 M.S. Hartzema

Canida, Lyle ** Aug. 10 May. 12 M.S. Winterstein

Douglas, Charles ** Aug. 05 Aug. 11 Ph.D. Ried

Eworuke, Efe Aug. 08 May. 13 Ph.D. Winterstein

Folmar, David ** Aug. 09 Dec. 11 M.S. Segal

Guo, Jennifer ** Aug. 08 Aug. 11 Ph.D. Hartzema

Hong, Evelyn ** Aug. 10 May. 12 M.S. Segal

Houtchens, Amy ** Aug. 10 May. 12 M.S. Kimberlin

Knox, Caitlin Aug. 09 May. 13 Ph.D. Winterstein

Lee, Christine Aug. 07 Dec. 12 Ph.D. Segal

Lester, Jean ** Aug. 10 May. 12 M.S. Lipowski

Linden, Stephan Aug. 07 Dec. 12 Ph.D. Winterstein

Liu, Wei Aug. 10 May. 14 Ph.D. Winterstein

Liu, Xinyue Aug. 10 May. 14 Ph.D. Winterstein

Ma, Qinli Aug. 07 Dec. 12 Ph.D. Kauf

Munoz, Monica Aug. 10 May. 12 M.S. Delaney

Murimi, Irene Aug. 10 May. 14 Ph.D. Kimberlin

Okoro, Olihe Aug. 09 May. 13 Ph.D. Odedina

Pepe, Salvatore ** Aug. 10 May. 12 M.S. Delaney

Pham, Hanah ** Aug. 10 May. 12 M.S. Kauf

Ritho, Jane Aug. 05 Dec. 12 Ph.D. Hartzema

Rosenthal, Rachel Aug. 09 May. 13 Ph.D. Segal

Schelfhout, Jonathan Aug. 09 May. 13 Ph.D. Hartzema

Seto, Tom * June. 11 Left Prog Ph.D. Kimberlin

Stojanovic, Danijela Aug. 10 May. 14 Ph.D. Smith & Delaney

VoQui, Jessica ** Aug. 10 May. 12 M.S. Winterstein

Vu, Hong ** Aug. 10 May. 12 M.S. Kimberlin

Wen, Xueron (Sharon) Aug. 08 May. 13 Ph.D. Hartzema

Pharmacodynamics Bruce, Erin Aug. 08 Dec. 12 Ph.D. Katovich

Dutta, Garima ** Aug. 06 May. 12 Ph.D. Liu

Feng, Xiaodi Aug. 07 Dec. 12 Ph.D. Keller-Wood

Haslach, Erica ** Aug. 06 Aug. 11 Ph.D. Haskell-Luevano

Kasper, James Aug. 06 Dec. 12 Ph.D. Peris

Liu, Yue Aug. 07 Dec. 12 Ph.D. Liu

MacFadyen, Kaley Ann * Aug. 11 May. 15 Ph.D. Peris

Pati, Dipanwita July. 10 May. 14 Ph.D. Frazier

Rathinasabapthy, Anandharajan June. 09 May. 13 Ph.D. Katovich

Schaub, Jay ** Aug. 07 Aug. 11 Ph.D. Haskell-Luevano

Sharma, Heera ** Aug. 06 Dec. 11 Ph.D. Liu

Tikamdas, Rajiv Harish July. 10 May. 14 Ph.D. Liu

Wang, Lei * Aug. 11 May. 15 Ph.D. Peris

Wang, Yunyang June. 09 May. 13 Ph.D. Ellis

* new students entering a graduate program during FY 11/12 ** students who graduated with an M.S. or Ph.D. during FY 11/12

7

Table 3: Graduate Student Demographics in Residential Programs

Gender Citizenship American Minority

US Foreign Black Hispanic Asian/Island

Pacific

Indian/

Alaskan

# % # % # % # % # % # % # %

Total/% 93 36 38.7% 57 61.3% 1 1.1% 2 2.2% 5 5.4% 1 2.8%

Male 38 40.9% 15 39.5% 23 60.5% 0 0.0% 1 2.6% 1 2.6% 1 6.7%

Female 55 59.1% 21 38.2% 34 61.8% 1 1.8% 1 1.8% 4 7.3% 0 0.0%

Table 4: Residential Graduate Students, Fellows, Visiting Scholars and Exchange Students

Department/Center Graduate

Students

Post-doctoral

Fellows

Visiting

Scholars

Exchange

Students

Medicinal Chemistry 14 11 0 4

Pharmaceutics 25 6 0 28

Pharmacodynamics 14 6 0 0

Pharmaceutical Outcomes and Policy 29 1 0 0

Pharmacotherapy & Translational Research 11 8 0 0

COLLEGE TOTAL 93 32 0 32

Table 5: GPA and Test Scores of Graduate Students in Residential Programs Class GPA GRE TOEFL TSE

Verbal Quant. Total

COLLEGE TOTAL (93)* 3.59 473 693 1213 97 85

FY 11/12 Class (12) 3.69 493 753 1245 99 N/A * numbers in parenthesis denote student population

Table 6: Post-doctoral Fellows, Scientists and Visiting Scholars Department/Center Name Mentor Home Country

Medicinal Chemistry Canal, Clinton Booth USA

Chen, Qi Yin Luesch China

Kim, Myong Sang Booth Korea

Liu, Yanxia Luesch China

McManis, James Bergeron USA

Ratnayake, Ranjala Luesch Sri Lanka

Sakhuja, Rajeev Booth India

Sintjago, Tania Booth USA

Villa, Nancy Booth Columbia

Zhang, Wei Luesch China

Canal, Clinton Booth USA

Pharmaceutics/Center for Jadhov, Manoj Hochhaus India

Drug Discovery & Center for Lu, Yuanqing Song China

Drug Interaction Research Sampath, Chetham Butterweck India

and Education Singh, Rajendra Derendorf India

Singh, Ravi Derendorf Canada

Xiling, Jiang Schmidt China

Pharmaceutical Outcomes and Policy Yang, Tsu-Hsuan Segal USA

8

Table 6: Post-doctoral Fellows and Visiting Scholars (cont.) Department/Center Name Mentor Home Country

Pharmacodynamics Hofmann, Mackenzie Frazier USA

Kabakov, Anatoli Frazier Russia

Li, Zhimin Peris China

Qi, Yanfei Katovich China

Shenoy, Vinayak Katovich India

Yao, Hua Haskell-Luevano China

Pharmacotherapy & Translational Dietrich, Eric Gums USA

Research/ Center for Elliott, Jennifer Sando USA

Pharmacogenomics McDonough, Caitrin Johnson USA

Mohamed, Mohamed E. Frye Egypt

Patel, Vinita Angaran USA

Smith, Carolyn Munyer USA

Vandell, Alexander Johnson USA

Wilcox, Alisa Taylor USA

PharmD/Ph.D. Students in Graduate Programs

The University of Florida, College of Pharmacy offers a Joint Doctor of Pharmacy (PharmD) and Doctor of Philosophy

(Ph.D.) Degree program for qualified Doctor of Pharmacy students who are interested in accelerated graduate studies. The

purpose of this program is to prepare clinically oriented pharmaceutical scientists. Through the selection of appropriate

graduate level courses and attainment of research skills and experience through research clerkships, students in the Doctor of

Pharmacy program can receive advanced standing in one of the graduate pharmaceutical science disciplines in the College of

Pharmacy. The joint degree program enables students to attain both degrees within a time frame of approximately nine years of

study from the beginning of college. This includes at least two years of prepharmacy studies, four years of professional

education, and approximately three to four years of graduate studies.

Due to the increasing interest from our PharmD students in the Clinical Pharmaceutical Sciences Program in our

Department of Pharmacotherapy & Translational Research and Department of Pharmaceutics, we have experienced a

resurgence of the PharmD/Ph.D. program in recent years. Our first student to complete the PharmD/Ph.D. track was in May

2005 in our POP Department. We have a total of 10 PharmD/Ph.D. students completing the joint degree program. Six students

have completed their PharmD curriculum and have now entered the Ph.D. program and 4 students are currently finishing their

PharmD degree and will enter the Ph.D. portion of the joint program in the next few years. A complete listing of

PharmD/Ph.D. students is listed in Table 7.

Table 7: PharmD/Ph.D. Students Engaged in COP Graduate Residential Programs

Student Name Department/Program

Expected Graduation Year

PharmD Ph.D.

Completed the Ph.D. Degree:

Heather Davis Pharmaceutics/PTR*/CST** 2007 2011

Melonie Stanton Pharmaceutics/PTR*/CST** 2006 2012

Completing the Ph.D. Degree:

Mariellen Moore Pharmaceutics/PTR*/CST** 2007 2012

Jason Karnes Pharmaceutics/PTR*/CST** 2008 2012

Daniel Gonzalez Pharmaceutics/PTR*/CST** 2008 2012

Eric Egelund Pharmaceutics/PTR*/CST** 2009 2013

Completing the PharmD Degree:

Nancy Gillis Pharmaceutics/PTR*/CST** 2012 2016

Donna Simpson Pharmaceutical Outcomes and Policy 2012 2016

Juan Hincapie-Castillo Pharmaceutical Outcomes and Policy 2013 2017

* PTR - Pharmacotherapy & Translational Research ** CST - Clinical Science Tract

http://www.cop.ufl.edu/studaff/phd.pdf

http://www.cop.ufl.edu/studaff/phd.pdf

9

FDA/CDER Students in the Master’s Program

This year was the fourth year of our graduate training program with FDA/CDER. Table 8 below lists students who

graduated in Spring 2012. Due to governmental budget constraints there will be no recruitment of students for the new

academic year.

Table 8: FDA/CDER Students in Master’s Residential Programs

Student Name Previous Institution Year Entered Program

Steven Bird Northeastern University 2010

Lyle Canida University of Florida 2010

Evelyn Hong University of Nebraska Medical Center 2010

Amy Houtchens University of Maryland Baltimore 2010

Jean Lester Lake Erie College of Osteopathic Medicine 2010

Monica Munoz Texas Tech University 2010

Salvatore Pepe Northeastern University 2010

Hanah Pham Hampton University 2010

Jessica VoQui Virginia Commonwealth University 2010

Hong Vu Palm Beach Atlantic University 2010

Graduate Student Recruitment Activities

Recruitment of graduate students was decentralized in 1991 and placed in the hands of the individual departments. As

such, departments are now responsible for their own recruitment brochures and strategies for graduate student recruitment.

Whenever possible, requests for application materials that come through the ORGS are now sent to the departments.

However, when applicants do not specify a graduate specialty in their letter of inquiry the ORGS handles these requests. To

streamline the process, a letter (see Appendix A) describing the individual graduate programs/specialties and identifying the

graduate coordinators of each graduate specialty is sent to each applicant. In this letter, applicants are encouraged to access

information from the COP home page on the Web.

Graduate student application activity for FY 11/12 for each of the departments is illustrated in Table 9. The College

received 238 completed applications. Of the 238 completed applications received by the departments, only 27 (or 11.3%) of

the applicants were accepted, of which 21 students (or 77.8% of the potential students) will enter our graduate programs for FY

12/13.

Table 9: Departmental Graduate Student Recruitment Activity

Department # Completed # Applications % # Applicants %

Applications Accepted Accepted Entered Entered

Medicinal Chemistry 74 6 6.8% 4 60.0%

Pharmaceutics 88 7 8.0% 5 71.4%

Pharmacodynamics 33 3 9.1% 3 100.0%

Pharmaceutical Outcomes and Policy 37 10 27.0% 8 80.0%

Pharmacotherapy & Trans. Research 7 2 28.6% 2 100.0%

COLLEGE TOTAL 238 27 11.3% 21 77.8%

Exchange Students in the College of Pharmacy

Each year many exchange students visit the COP for a 3-4 month period to help them develop in their research as part of

the core curriculum from their home country. Table 10 lists the 32 students hosted by the COP during this academic year.

10

Table 10: Exchange Students Department Student Name Mentor Home Country

Pharmaceutics/ Center for Drug Alfadhl, Salman Hochhaus Saudi Arabia

Discovery & Center for Drug Beck, Christian Derendorf Germany

Interaction Research and Education Burger, Gisela Derendorf Germany

Falcao, Nivea Derendorf Brazil

Gonzales, Sylvie Derendorf France

Habteab, Helen Derendorf Germany

Herlan, Laura Derendorf Germany

Hufendiek, Peter Derendorf Germany

Jadhav, Manoj Hochhaus India

Klein, Nadine Butterweck Germany

Krohne, Maren Butterweck Germany

Kremser, Eva Derendorf Germany

Lechavalier, Lucie Derendorf France

Panzovata, Giscardo Derendorf Italy

Raab, Annette Derendorf Germany

Richter, Christiane Butterweck Germany

Rolle, Vanessa Hochhaus Switzerland

Schilling, Damaris Butterweck Germany

Schwanke, Raquel Butterweck Brazil

Spahn, Saskia Derendorf Germany

Straub, Julie Derendorf Germany

Tavares Cavalcanti, Noely Derendorf Brazil

Volkner, Alexander Derendorf Germany

Wedler, Jonas Derendorf Germany

Wegmann, Sascha Derendorf Germany

Yu, Mingming Derendorf China

Zhang, Ruxue Butterweck China

Medicinal Chemistry Fuerst, Michael Luesch Germany

Ghaly, Peter James Egypt

Mievre, Quentin James France

Schneider, Jennifer James Germany

Pharmaceutical Outcomes and Policy Boteman, Lea Winterstein Germany

Graduate Student Graduation Activities

During this academic year the COP had 14 students finish their graduate program and earn a Ph.D. degree and 11 who

earned a Master’s degree. The following are the graduates according to commencement date.

Pharmaceutical Science Ph.D. Degrees Conferred

AUGUST 2011 (SUMMER COMMENCEMENT)

Name: Dr. Charles Allen Douglas

Dissertation Title: Towards an Operational Definition of Pharmacy Clinical Competency

Faculty Mentor: Dr. L. Douglas Ried, Professor

Department: Pharmaceutical Outcomes and Policy

Previous Degree: B.S. in Business, University of Phoenix; MBA in Strategy, Peter F. Drucker Graduate School

of Management

Dr. Douglas assumed a position as an Assistant Professor in Pharmacy-Academic Support at Texas A&M University.

11

Name: Dr. Jennifer D. Guo

Dissertation Title: Random-effects Approaches Comparisons in Meta-analysis: Data Simulation with Binomial

Outcomes

Faculty Mentor: Dr. Abraham Hartzema, Professor


Previous Degree: M.S. in Pharmacology, Peking University; M.S. in Pharmaceutical Outcomes and Policy,

University of North Carolina at Chapel Hill

Dr. Guo assumed a position as a Pharmacoepidemiologist at UCB Biosciences, Inc., Raleigh, NC.

Name: Dr. Erica Haslach

Dissertation Title: Rational Drug Design Approaches Targeting the Mouse and Human Melanocortin Receptors

Faculty Mentor: Dr. Carrie Haskell-Luevano, Professor

Department: Pharmacodynamics

Previous Degree: B.S. in Chemistry, Shippensburg University

Dr. Haslach assumed a position as an Adjunct Chemistry Professor, Oklahoma City Community College.

Name: Dr. Kristen Merritt

Dissertation Title: Cloning and Characterization of Cytosolic Sulfotransferases from Channel Catfish Liver

Faculty Mentor: Dr. Margaret James, Professor

Department: Medicinal Chemistry

Previous Degree: B.S. in Chemistry, M.S. in Food Science and Human Nutrition, University of Florida

Dr. Merritt assumed a position as a Sr. Biological Scientist at Florida Biologix, Alachua, FL.

Name: Dr. Runa Naik

Dissertation Title: Pharmacokinetic Pharmacodynamic Characterization of JNJ-Q2, A Novel Fluoroquinolone

Faculty Mentor: Dr. Hartmut Derendorf, Distinguished Professor

Department: Pharmaceutics

Previous Degree: B.S. in Pharmacy, Rajiv Gandhi University of Health Sciences

Dr. Naik is currently looking for employment.

Name: Dr. Jay Schaub

Dissertation Title: Effects of Voluntary Exercise on the Central Melanocortin Receptor Knockout Mice

Faculty Mentor: Dr. Carrie Haskell-Luevano, Professor


Previous Degree: B.S. in Chemistry, University of Florida

Dr. Schaub assumed a position as a High School Science Teacher, Gainesville High School, Gainesville, FL.

Name: Dr. Sean Travers

Dissertation Title: Characterization of the Molecular Determinants for Class A G Protein-coupled Receptor

Ligand Binding and Function: Drug Discovery Targeting the Histamine H1Receptor

Faculty Mentor: Dr. Raymond Booth, Professor


Previous Degree: B.S. in Chemistry, Elon University

Dr. Travers assumed a position as a Sales Associate at Anatom Technologies, Baldwin, MD.

Name: Dr. Manuela de Lima Toccafondo Vieira

Dissertation Title: Intravenous Microdialysis and Physiologically-based Pharmacokinetic Modeling as Tools to

Evaluate Pharmacokinetics and Drug-Drug Interactions

Faculty Mentor: Dr. Hartmut Derendorf, Distinguished Professor


Previous Degree: B.S. and M.S. in Pharmaceutical Sciences, Universidade Federal de Minas Gerais

Dr. Vieira assumed a position as a Post-doctoral Fellow with the Food and Drug Administration, Washington DC.

12

DECEMBER 2011 (FALL COMMENCEMENT)

Name: Dr. Matthias Fueth

Dissertation Title: In Vivo and In Vitro Protective Effects of Alpha-1 Antitrypsin on Doxorubicin-induced

Cytotoxicity

Faculty Mentor: Dr. Sihong Song, Associate Professor


Previous Degrees: Apotheker in Pharmacy, Technisch Universitaet Braunschweig

Dr. Fueth assumed a position as a Post-doctoral Fellow in the Department of Pharmaceutics, College of Pharmacy, University

of Florida.

Name: Dr. Heera Sharma

Dissertation Title: Cooperative Dopaminergic Neurotoxicity of Organochlorine Pesticides

Faculty Mentor: Dr. Bin Liu, Associate Professor


Previous Degrees: B.S. in Pharmacy, Himalayan Pharmacy Institute; B.S. in Information Technology, Sikkim

Manipal University

Dr. Sharma assumed a position as a Post-doctoral Fellow in the Department of Pathology, College of Medicine, Case Western

Reserve University, Cleveland, OH.

MAY 2012 (SPRING COMMENCEMENT)

Name: Dr. Heather Marie Davis

Dissertation Title: Molecular Analysis and Pharmacogenetic Assessment of Calcium Signaling Pathway

Variation

Faculty Mentor: Dr. Julie Johnson, Professor

Department: Pharmacotherapy &Translational Research

Previous Degrees: PharmD, University of Florida

Dr. Davis assumed a position as a Pharmacist at CVS, Gainesville, FL.

Name: Dr. Garima Dutta

Dissertation Title: Dopaminergic Cystatin C: A Key Player in Neuron-microglia Interplay

Faculty Mentor: Dr. Bin Liu, Associate Professor


Previous Degrees: B.S. in Pharmacy, Delhi Institute of Pharmaceutical Sciences and Research

Dr. Dutta assumed a position as a Post-doctoral Fellow in the Department of Neurobiology, School of Medicine, UCLA.

Name: Dr. Huong Le Moldthan

Dissertation Title: The Protective Effects of Plasma Gelsolin and Alpha 1-Antitrypsin on Ischemic Stroke

Outcome in Rats

Faculty Mentor: Dr. Sihong Song, Associate Professor


Previous Degrees: B.S. in Pharmacy, Hanoi College of Pharmacy; M.S. in Pharmaceutical Sciences, Utrecht

University

Dr. Moldthan is currently looking for employment.

Name: Dr. Melonie Stanton

Dissertation Title: Organic Anion-Transporting Polypeptide (OATP) Family: Contribution of Genetic Variation

and Botanical Interactions to Variability in Drug Disposition and Response

Faculty Mentor: Dr. Reginald Frye, Associate Professor

Department: Pharmacotherapy & Translational Research


Dr. Stanton assumed a position as a Post-doctoral Fellow at Shands Hospital, Gainesville, FL.

13

Pharmaceutical Science Master’s Degrees Conferred

DECEMBER 2011 (FALL COMMENCEMENT)

Name: Mr. David Folmar

Faculty Mentor: Dr. Richard Segal, Professor


Previous Degrees: B.S. in Pharmacy, Auburn University

Mr. Fulmar is continuing his active duty with the United States Air Force as a Pharmacy Consultant to the Department of

Defense Pharmacoeconomic Center, San Antonio, TX.

MAY 2012 (SPRING COMMENCEMENT)

Name: Dr. Steven Bird

Faculty Mentor: Dr. Abraham Hartzema, Professor


Previous Degrees: PharmD, Northeastern University

Dr. Bird assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Lyle Canida

Faculty Mentor: Dr. Almut Winterstein, Professor



Dr. Canida assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Evelyn Hong

Faculty Mentor: Dr. Richard Segal, Professor


Previous Degrees: PharmD, University of Nebraska Medical Center

Dr. Hong assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Amy Houtchens

Faculty Mentor: Dr. Carole Kimberlin, Professor


Previous Degrees: PharmD, University of Maryland Baltimore

Dr. Houtchens assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Jean Lester

Faculty Mentor: Dr. Earlene Lipowski, Professor


Previous Degrees: PharmD, Lake Erie College of Osteopathic Medicine

Dr. Lester assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Monica Munoz

Faculty Mentor: Dr. Joseph C. Delaney, Assistant Professor


Previous Degrees: PharmD, Texas Tech University

Dr. Munoz assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

14

Name: Dr. Salvatore Pepe

Faculty Mentor: Dr. Joseph C. Delaney, Assistant Professor


Previous Degrees: PharmD, Northeastern University

Dr. Pepe assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Hanah Pham

Faculty Mentor: Dr. Teresa Kauf, Associate Professor


Previous Degrees: PharmD, Hampton University

Dr. Pham assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Jessica VoQui

Faculty Mentor: Dr. Almut Winterstein, Professor


Previous Degrees: PharmD, Virginia Commonwealth University

Dr. VoQui assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Name: Dr. Hong Vu

Faculty Mentor: Dr. Carole Kimberlin, Professor


Previous Degrees: PharmD, Palm Beach Atlantic University

Dr. Vu assumed a position as a commissioned officer with the Food and Drug Administration, Washington DC.

Forensic Sciences Master’s Degrees Conferred

This year in the Forensics Programs there were 497 students enrolled in one of the four Master’s programs and 182

students enrolled in one of the six certificate programs. Within the Master’s programs there was a total of 106 students who

graduated; 4 (3.8%) from the Drug Chemistry program, 34 (32.1%) from the DNA and Serology program, 56 (52.8%) from the

Forensic Science program, and 12 (11.3%) from the Pharmaceutical Chemistry program. Within the certificate programs there

was a total of 119 students who received their certificate; 8 (6.7%) from the Drug Chemistry program, 37 (31.1%) from the

DNA and Serology program, 20 (16.8%) from the Death Investigation program, 25 (21%) from Pharmaceutical Chemistry

program, 26 (21.9%) from the Forensic Toxicology program, 1 (0.8%) from the Clinical Toxicology program, and 2 (1.7%)

from the Environmental Forensics program. Listed in Table 11 are those students who have graduated with their Master’s in

one of the Forensic Sciences programs.

Table 11: Master’s Graduates in the Forensic Sciences Program Program Name

Summer 2011

DNA and Serology Arnold, David Cannon, Amory

Barkwill, Sharon Chang, Candice

Beamer, Vickie Fair, Elisa

Benvie, Sarah Guidry, Clair

Browder, Clare Peacock, Mary

Caceres, Gabriel

Drug Chemistry Boyd, Sarah Rowshan, Hooman

Lynn, Nicholas

Pharmaceutical Chemistry Miller, Rebecca Roberts, Bryce

Stultz, Megan Wilkinson, Robert

Forensic Science Biglin, Danielle Coleman, Scott

Braget, Amanda Hardin, Richard

Buccieri, Natalie Huene, Lauren

Bunker, Allison Jeko, Katie

Civil, Edward Klopcic, Sandra

15

Table 11: Master’s Graduates in the Forensic Sciences Program (cont.) Program Name

Summer 2011 (cont.)

Forensic Science (cont.) Marion, Monica Skinner, Brady

Mateu, Dania Smith, Sherry

Mizell, Kenyetta Tatarek-Adams, Elaine

Montoya, Oscar Toomer, Cicely

Mueller, Kyle Wisdom, Daniel

Parsons, Heather

Fall 2011

DNA and Serology Isherwood, Elaine Lease, Kristen

Johnson, Scott Scarpola, Jessica

Kerski, Anelle Tsangaras, Kyriakos

Kobayashi, Marie Wickersham, Alexis

Kurtzner, Christine

Pharmaceutical Chemistry Babos, Mary Beth Widden, Michael

Onimus, Matthew

Forensic Science Baughman, Seneca Laitinen, Fred

Black, Alan Lavine, Lawrence

Breen, Deborah Morris, Melissa

Crowetz, Robert Morrison, Glen

Gillaspie, Daniel Parr, Kathy

Heintz, Tyhra Rauch, Jene

Hendrickson, Elyse Rolnik, Rochelle

Hoza, Ashley Testa, Gina

Johnson, Kathleen Wunsch, Christina

Joseph, Karrel

Spring 2012

DNA and Serology Beach, Adam Lindley, Daniel

Casper, Nicole Naleid, Trevor

Corbin, Alisha Ramsey, Edward

Flint, Lauren Ramsi, Parisa

Grant, Rachel Setlak, Jennifer

Humphries, Brandon Sosebee, Ashleigh

Kasprzyk, Christine Whitson, Dustin

Drug Chemistry Hite, Breanne

Pharmaceutical Chemistry DiSante, Anne Marie Onsotti, Edward

Fesl, Adam Yoder, Carhyl

Kuipers, Joshua

Forensic Science Collie, Will Pulido, Desiree

Dill, Tonya Rautanen, William

Ernst, Erik Richardson, Kristie

Kazaros, Charles Rovensky, Joanne

Knox, Michael Showell, Megan

Kline, Jay Stamp, John

Kraul, Lauren Trainer, Benjamin

Messer, Brett Zecker, Lauren

Pharmacy Regulations and Policy Master’s Degrees Conferred

This year in the Pharmacy Regulation and Policy Program there were 172 students enrolled in one of the six programs

offered; Pharmacy Regulations and Policy, Applied Pharmacoeconomics, Clinical Research Regulation & Ethics, Patient

Safety & Risk Management, Drug Regulatory Affairs, and Institutional Pharmacy Leadership. Within the Master’s programs

there was a total of 53 students who graduated; 7 (13.2%) from the Pharmacy Regulation and Policy program; 26 (49.1%) from

the Applied Pharmacoeconomics program; 3 (5.7%) from the Clinical Research Regulations and Ethics program; 7 (13.2%)

from the Drug Regulatory Affairs program; 6 (11.3%) from the Patient Safety and Risk Management program; and 4 (7.5%)

16

from the Institutional Pharmacy Leadership program. Listed in Table 12 are those students who have graduated with their

Master’s in one of the Pharmacy Regulations and Policy programs.

Table 12: Master's Graduates in the Pharmacy Regulations and Policy Program Program Name

Summer 2011

Applied Pharmacoeconomics Philbin, Michael Steelman, Douglas

Rafi, John

Institutional Pharmacy Leadership Bell, Gabrielle Temple-Cooper, Mary

Patient Safety and Risk Management Buwe, Patrice

Pharmacy Regulations and Policy Berry, John

Fall 2011

Applied Pharmacoeconomics Charbonnet, Steve Lowry, Patrick

Hogan, Michael Walker-Fairclough, Jamie

Clinical Research Regulations and Ethics Wuerdeman, Erin

Drug Regulatory Affairs Benson, Amy Williams, Wayner

West, Kristin

Patient Safety and Risk Management Emery, Betty

Pharmacy Regulations and Policy Gilmore, Sheila Leonard, Melvin

Spring 2012

Applied Pharmacoeconomics Al-Najjar, Fouad Liao, Richard

Baird, Lisa Lok, Terence

Burford, Brian Patridge, Robert

Burttram, Roslyn Pruitt, Kevin

Carter, Jerrica Ramsey, Matthew

Crook, Shane Roman, Brian

Dauer, Stephanie Sepulveda, Michael

Harris, Michelle Zagadailov, Erin

Hawthorne, Hamilton Zelman, David

Hymel, Lisa

Clinical Research Regulations and Ethics Leinbach, Ashley Shah, Sweta

Drug Regulatory Affairs Aurand, Anelis Klaus, Kelly

Jain, Sumit Watson, Sharon

Institutional Pharmacy Leadership Poore, Michelle Simmons, Marrolyn

Patient Safety and Risk Management Bartlett, Robin Pinchevsky, Lyndsy

Hidalgo, Kathleen Smith, Tara

Pharmacy Regulations and Policy Garbutt, Brandi Vo, Bang

Marshall-Frank, Roxanne Yeske-Amato, Sharon

Graduate Student Funding and Awards

Awardees are recommended to the Graduate Studies Committee or the Executive Associate Dean for Research and

Graduate Studies by their respective graduate coordinator or departmental chair. Based on the student’s academic credentials

and letters of support, awardees are selected by the Executive Associate Dean for Research and Graduate Studies in discussion

with the Graduate Studies Committee.

The COP carried the major load of the funding of graduate student stipends by supporting 61 graduate student stipends;

eight students received support from extramural research grants; seven students were funded by their home government; and

eight students funded their own graduate education this year. Ten students received Grinter Awards as a supplement to their

state funding. Graduate stipends ranged from $14,400 to $25,750 with an average overall stipend of $18,358.

Nine graduate student fellowship proposals totaling $213,196 were submitted to extramural sources this year. Agencies to

which proposals were submitted were the American Foundation for Pharmaceutical Education (AFPE), Agency for Healthcare

Research and Quality (AHRQ), Pharmaceutical Research and Manufacturers of American Foundation, and PhRMA

Foundation.

17

Graduate School Fellowship

Beginning Fall Semester 1999, the University of Florida offered the Graduate School Fellowship program with the

express interest of increasing graduate enrollment and attracting high quality students to each graduate program at the

University. This fellowship represents the highest graduate student award available at the University and is funded at nationally

competitive levels starting at $22,500/year for four years plus all tuition remuneration, and full health insurance coverage. The

College of Pharmacy received five additional Graduate School Fellowships. The recipients of the Graduate School

Fellowships are:

Guanming Chen Pharmaceutics FY 11/12

Daniel Felsing Medicinal Chemistry FY 11/12

Tom Seto Pharmaceutical Outcomes and Policy FY 11/12

Mohamed Shahin Pharmacotherapy & Translational Research FY 11/12

Lei Wang Pharmacodynamics FY 11/12

Michelle Bousquet Medicinal Chemistry FY 10/11

Marina Kawaguchi Pharmacotherapy & Translational Research FY 10/11

Irene Murimi Pharmaceutical Outcomes and Policy FY 10/11

Dipanwita Pati Pharmacodynamics FY 10/11

Sherwin Sy Pharmaceutics FY 10/11

Bhargava Kandala Pharmaceutics FY 09/10

Jennifer Synovec Medicinal Chemistry FY 09/10

Yunyang Wang Pharmacodynamics FY 09/10

Greg Welder Pharmacotherapy & Translational Research FY 09/10

Lisa Zeigler Pharmaceutical Outcomes and Policy FY 09/10

Daniel Gonzalez Pharmacotherapy & Translational Research FY 08/09

Jason Karnes Pharmacotherapy & Translational Research FY 08/09

Krishnakanth Kondabolu Medicinal Chemistry FY 08/09

Kyle Lokuta Pharmacodynamics FY 08/09

Efe Odia Pharmaceutical Outcomes and Policy FY 08/09

Wan Sun Pharmaceutics FY 08/09

Fullbright Capes Scholarships

The CAPES Foundation is a Brazilian government agency awarding scholarship grants to graduate students at universities

and research centers in Brazil and abroad. Its central purpose is to coordinate efforts to improve the quality of faculties and

staff in higher education through its grant program. CAPES is particularly concerned with the training of researchers in

doctorate, pre-doctoral short-term research and post-doctorate scholar programs. At present CAPES supports about 22,000

students in Brazilian graduate programs and 1,500 in other countries. The recipient of the Fullbright Capes Scholarship is:

Manuela Vieira Pharmaceutics FY 07/08

Ruffolo Fellowship

The Robert & Stephany Ruffolo Graduate Student Fellowship is awarded to a senior Pharmacodynamics graduate

student who has demonstrated excellence in his/her graduate studies, including excellence in the classroom and in research,

publication of their research, presentation at national meetings, and commitment to a scientific career. This award consists of

an annual stipend supplement of $1,500. The awardee is selected by the faculty in Pharmacodynamics. The recipient of the

Robert & Stephany Ruffolo Graduate Student Fellowship is:

Erin Bruce Pharmacodynamics FY 08/09

Mary Kay Owens Fellowship

The Mary Kay Owens Fellowship is awarded to two graduate students each year in the Department of Pharmaceutical

Outcomes and Policy. One of the students selected must be working in conjunction with the Center for Medicaid with a focus

18

on analytical research, education and training in the areas of integrated, coordinated care models and technologies to promote

patient-centered, quality driven healthcare solutions. This award consists of an annual stipend of $20,000. The awardees are

selected by the faculty in Pharmaceutical Outcomes and Policy. The recipients of the Mary Kay Owen Fellowships are:

Stephan Linden Pharmaceutical Outcomes and Policy FY 10/11

Lily Ma Pharmaceutical Outcomes and Policy FY 10/11

DuBow Fellowship

The Lawrence J. DuBow Fellowship is awarded to a graduate student to support their research and education in the

Department of Pharmaceutical Outcomes and Policy, especially for students involved with research related to pediatrics. This

award consists of an annual stipend supplement of $5,000. The awardee is selected by the faculty in Pharmaceutical Outcomes

and Policy. The recipient of the DuBow Fellowship is:

Efe Odia Pharmaceutical Outcomes and Policy FY 10/11

Grinter Awards

Originated in 1988, the intent of the Grinter Awards program was to serve as a mechanism to recruit graduate students

with outstanding academic credentials into one of the College’s graduate programs. These awards come from monies allocated

from ORTGE on a college-by-college basis and supplement our existing state stipends, an additional $3,000 per year for a

maximum of 3 years ($9,000 total award). A statistical summary of the Grinter Awards in the COP is illustrated in Table 13.

Overall, we have had a 69.9% acceptance of Grinter Awards by prospective students. Sixty-three percent of the COP Grinter

Awardees have graduated from the COP program with either a Ph.D. or M.S. degree. The overall average GPA for the Grinter

Awardees is 3.52 with a GRE of 1224 and a TOEFL of 105.

Table 13: Statistical Summary of the Grinter Program – 1988 to Present

Statistic Overall % 11/12 Class

Total number offered 123 3

Total number accepted 86 69.9% 3

Total number graduated 54 62.8%

Total number still enrolled: past & present 20 23.3%

Number of active awardees 10 11.6% 3

Grade Point Average (GPA) 3.52 3.67

Graduate Record Exam -GRE (Verbal + Quant.) 1224 1157

Test of English as a Foreign Language (TOEFL) 105 N/A

This year the COP offered 3 new Grinter Awards. The recipients of the Grinter Awards are:

Sharvari Bhagwat Pharmaceutics FY 11/12

Kaley MacFadyen Pharmacodynamics FY 11/12

Guo Zhong Medicinal Chemistry FY 11/12

Erin Jackson Medicinal Chemistry FY 10/11

Xinyue Liu Pharmaceutical Outcomes and Policy FY 10/11

Danijela Stojanovic Pharmaceutical Outcomes and Policy FY 10/11

Rajiv Tikamdas Pharmacodynamics FY 10/11

Mongjen Chen Pharmaceutics FY 09/10

Caitlin Knox Pharmaceutical Outcomes and Policy FY 09/10

Rachel Rosenthal Pharmaceutical Outcomes and Policy FY 09/10

19

25th


A number of graduate students, post-doctoral fellows and professional students received cash awards and commemorative

plaques for participating in the COP “Annual Research Showcase and Awards Recognition Day”. The specifics of this

daylong event and the award winners are listed in ORGS Coordinated Events for the COP.

Graduate Student Awards and Recognitions

Olihe Okoro, a graduate student in the Department of Pharmaceutical Outcomes and Policy, received the 2012-2013 Faculty

for the Future Fellowship Award from the Schlumberger Foundation. This award will provide up to $50,000 towards her

dissertation which focuses on developing a conceptual framework for medication use among black women living with

HIV/AIDS in Florida, and a care process model for improved adherence, optimum retention and improved health outcomes in

this population. Olihe is also the recipient of a $750 scholarship of the 2012 Marilyn Little Scholarship from the

International Committee of Altrusa International of Gainesville.

Melonie Stanton, a graduate student in the Department of Pharmacotherapy & Translational Research, along with Drs. Karen

Sando, Randell Doty, and Jennifer Elliott, were selected to receive the 2012 American Association of Colleges of Pharmacy

(AACP) Innovations in Teaching Award for their project entitled “Medication Mysteries Infinite Case Tool”, an interactive

tool with game-like features that allows 2nd

year professional students to practice multiple patient interview scenarios in a lab

setting.

Professional Student Awards and Recognitions

Juan Hincapie-Castillo, a professional student at the Jacksonville campus, was appointed to the American Society of

Health-System Pharmacists (ASHP) Council of Therapeutics by the ASHP President for a one year term ending with the

ASHP Annual House of Delegates Session in June 2013.

Donna Rivera, a professional student at the St. Petersburg campus, received a $7,500 scholarship from the 2012 Phi Lambda

Sigma American Foundation for Pharmaceutical Education (AFPE) First Year Graduate School Fellowship in

Pharmaceutical Sciences.

International Student Academic Awards

At the International Student Academic Awards Ceremony held November 17, 2011, in the Reitz Union Auditorium, five

of the College of Pharmacy’s international graduate students received a certificate award for outstanding academic

accomplishment. The recipients of the International Student Awards are:

Daniela Conrado Pharmaceutics

Marina Kawaguchi Pharmacotherapy & Translational Research

Wei Liu Pharmaceutical Outcomes and Policy

Yue Liu Pharmacodynamics

Lilibeth Salvador Medicinal Chemistry

Graduate Minority Activities

The ORGS has continued to work with the Graduate School’s Office of Graduate Minority Programs (OGMP) in

recruiting minority students into the College’s graduate programs. The ORGS filters information down to individual

departments concerning funding opportunities for both graduate minority students as well as undergraduate minority students

interested in a research career.

Names of interested minority students were passed on to the respective departmental chairs or graduate coordinators by

Dr. Michael McKenzie, Associate Dean for Professional Affairs, following his various recruiting trips to colleges for our

professional program. Each Department then follows up with a letter and application packet to the student(s) outlining their

respective graduate program and its objectives.

Return to Table of Contents

20

Research Activities in the College of Pharmacy

Grant and Contract Efforts and Funding

Pharmaceutical research continues to be a major effort within the College of Pharmacy at the University of Florida.

According to the American Association of Colleges of Pharmacy (AACP) annual listing of Colleges of Pharmacy and their

placement relative to Schools of Pharmacy engaged in active pharmaceutical research, the University of Florida was ranked 18th

this past year out of 74 schools with research programs as seen in Table 14. These placements are based solely on fiscal year

NIH funding (October to September of a given year).

Table 14: AACP Statistics for NIH Funding

NIH NIH Rank FTE Ph.D.’s NIH Support/ Rank

Fiscal Year Support FTE- Ph.D.

2007 $4,959,305 20 35 $141,494 23

2008 $6,401,646 14 34 $188,284 15

2009 $6,081,908 19 34 $178,880 22

2010 $6,849,361 18 37 $185,118 22

2011 $7,399,403 18 15* $493,294* 18*

* in FY 2011 the AACP no longer reports funding data based on FTE PhD’s, Instead this year and all future years will be

reported based on the number of funded Principal Investigators.

Our faculty members continue to be productive and are making efforts to obtain more extramural support for their

individual research efforts. During this year the ORGS processed a total of 124 extramural grant or contract applications from

the five Departments for a total of $87,045,370 in new grant dollars, see Table 15. This is a 40.7% increase in total dollars

requested when compared to FY 10/11, see Table 16. The majority of new proposals (75.8%) within the COP are proposals in

which the Principal Investigator (PI) is a faculty member within the COP (Tables 15 and 16). Research faculty members are

also encouraged to collaborate with other units within the University. Twenty-four percent of grants submitted were originated

outside of the College of Pharmacy.

Table 17 shows total extramural research dollars brought into the College over the last five fiscal years (from July to June of

a given fiscal year). This year our research funding dollars totaled $8,983,763 with 99 individual awards coming into the

College of Pharmacy. This represents a decrease in total funding by 15.4% although the number of awards received was the

same compared to FY 10/11.

During FY 11/12 departmental comparisons show that Pharmacotherapy & Translational Research brought in the highest

total of research dollars within the COP at 45% ($4,045,279). Pharmacodynamics was second at 19.3% ($1,737,022); followed

by Medicinal Chemistry at 16.7% ($1,505.112); Pharmaceutical Outcomes and Policy at 10.2% ($913,075); and Pharmaceutics

at 8.8% ($787,275).

TOTAL EXTRAMURAL FUNDING to the COP is illustrated in Table 18. Total extramural support includes not only

RESEARCH funds (also found in Table 17) but also those ADMINISTRATIVE funds that included support for educational

training activities. This year there were no additional ADMINISTRATIVE funds. Overall, Total Extramural Funding had a

decrease of 15.4% from FY 10/12 (Tables 18 and 19).

21

Table 15: Proposal Processing Summary Department Inside the College Outside the College Total

College Total

# Proposals 94 30 124

Total Amount $81,939,431 $5,105,939 $87,045,370

Medicinal Chemistry

# Proposals 13 11 24

Total Amount $20,875,710 $2,124,676 $23,000,386

Pharmaceutics

# Proposals 18 5 23

Total Amount $36,218,255 $985,040 $37,203,295

Pharmacodynamics

# Proposals 11 4 15

Total Amount $6,286,667 $766,818 $7,053,485

Pharm. Outcomes & Policy

# Proposals 23 2 25

Total Amount $5,631,332 $167,260 $5,798,592

Pharm. & Translational Research

# Proposals 29 8 37

Total Amount $12,927,467 $1,062,145 $13,989,612 Inside the College = PI was a COP faculty member; Outside the College = PI was outside the COP; COP personnel were co-investigators

Table 16: Proposal Processing Comparison Fiscal Year Inside the College Outside the College Total

FY 10/11

# proposals 103 28 131

Total Amount $54,027,344 $7,833,071 $61,860,415

FY 11/12

# proposals 94 30 124

Total Amount $81,939,431 $5,105,939 $87,045,370

Inside the College = PI was a COP faculty member; Outside the College = PI was outside the COP; COP personnel were co-investigators

22

Table 17: Extramural Research Dollars - FY 07/08 to FY 11/12

Department 07/08 08/09 09/10 10/11 11/12

Average

07/08 - 11/12

% of Total

11/12

COLLEGE TOTAL $7,192,475 $8,807,502 $10,550,670 $10,621,827 $8,983,763 $9,231,247 100.00%

F&A $1,337,594 $1,669,551 $1,944,971 $2,374,018 $1,688,991 $1,803,025 100.00%

# grants 91 100 101 99 99 98

%F&A 22.8% 23.4% 22.6% 28.8% 23.2% 24.2%

Medicinal Chemistry $1,633,481 $2,333,801 $1,949,202 $2,685,604 $1,501,112 $2,020,640 16.71%

F&A $404,829 $486,631 $474,817 $539,078 $338,066 $448,684 20.02%

# grants 13 14 10 12 10 12

%F&A 32.9% 26.3% 32.2% 25.1% 29.1% 29.1%

Pharmaceutics $1,361,814 $1,297,192 $1,249,516 $1,327,201 $787,275 $1,204,600 8.76%

F&A $321,903 $272,091 $268,065 $298,882 $115,211 $255,230 6.82%

# grants 19 24 17 14 13 17

%F&A 31.0% 26.5% 27.3% 29.1% 17.1% 26.2%

Pharmacodynamics $963,262 $1,695,696 $1,422,553 $1,343,491 $1,737,022 $1,432,405 19.34%

F&A $262,392 $492,574 $403,359 $389,791 $502,161 $410,055 29.73%

# grants 9 18 15 14 18 15

%F&A 37.4% 40.9% 39.6% 40.9% 40.7% 39.9%

Pharm. Outcomes and Policy $321,697 $716,193 $1,189,754 $394,685 $913,075 $707,081 10.16%

F&A $72,864 $142,039 $81,474 $94,293 $56,126 $89,359 3.32%

# grants 5 2 11 11 12 8

%F&A 29.3% 24.7% 7.4% 31.4% 6.5% 19.9%

Pharm. & Trans. Research $2,912,221 $2,764,620 $4,739,645 $4,870,847 $4,045,279 $3,866,522 45.03%

F&A $275,606 $276,216 $717,256 $1,051,974 $677,428 $599,696 40.11%

# grants 45.0 42.0 48.0 48.0 46.0 46

%F&A 10.5% 11.1% 17.8% 27.5% 20.1% 17.4%

F&A = Facilities and Administrative Costs

Table 18: Total Extramural Support - FY 07/08 to FY 11/12

Dept.

07/08 08/09 09/10 10/11

Average

11/12 07/08-11/12

COLLEGE TOTAL $7,232,617 $8,928,374 $10,631,032 $10,621,827 $8,983,763 $9,279,523

F&A $1,350,704 $1,689,699 $1,944,971 $2,374,018 $1,688,991 $1,809,677

# grants 92 104 103 99 99 99.4

%F&A 23.0% 23.3% 22.4% 28.8% 23.2% 24.1%

RESEARCH $7,192,475 $8,807,502 $10,550,670 $10,621,827 $8,983,763 $9,231,248

F&A $1,337,594 $1,669,551 $1,944,971 $2,374,018 $1,688,991 $1,803,025

# grants 91 100 101 99 99 98

%F&A 22.8% 23.4% 22.6% 28.8% 23.2% 24.2%

ADMINISTRATION $40,142 $120,872 $80,362 $0 $0 $48,275

F&A $13,110 $20,148 $0 $0 $0 $6,652

# grants 1 4 2 0 0 1.4

%F&A 48.5% 20.0% 0.0% 0.0% 0.0% 13.7%


23

Outlined below in Table 19 is a breakdown of the COP extramural support by sponsor type and number of awards for the

last two fiscal years. At 56.6%, just over half of the College’s extramural support comes from Federal Agencies. Federal dollars

were earmarked entirely for research purposes and showed a 23.7% decrease in dollars in spite of its 9.8% increase in the

number of awards this year from FY 10/11. State dollars decreased by half; Corporations and Companies showed an significant

increase of 108.3% in dollars received; and Foundation and Society monies also showed a considerable increase of 87.9% in

the dollars received compared to FY 10/11. The College experienced a decrease of 33.1% in funding within the “Other”

funding category from the previous year. Within this “Other” category are funds that include Miscellaneous Donor monies or

funds in which faculty members have unrestricted use to support their individual research programs.

Table 19: Comparison by Sponsor FY 10/11 FY 11/12

Sponsor Category # of awards Total Dollars # of Awards Total Dollars

Federal Agencies 51 $9,086,788 56 $6,930,207

Florida State Agencies 7 $683,868 4 $332,633

Corporations and Companies 28 $680,756 23 $1,417,711

Foundations and Societies 8 $156,360 13 $293,813

Other 5 $14,055 3 $9,400

Total Comparison 99 $10,621,827 99 $8,983,763

A more complete breakdown and two-year comparison of sponsor categories, number of awards and total dollars including

F&A costs can be seen in Tables 20-24. In Appendix B a complete listing of all extramural support by Department and

Faculty members can be found.

Table 20: Federal Agencies Comparison

FY 10/11 FY 11/12

Sponsor Count Total F&A Count Total F&A

AHCA 1 $323,025 $64,605 1 $192,650 $17,514

AHRQ 1 $192,015 $55,479 1 $25,379 $8,202

Food & Drug Administration 2 $1,000,000 $245,990 1 $539,114 $0

Natl Cntr for Dis Control & Prev 1 $22,500 $7,142

NIH 45 $7,530,511 $1,787,773 53 $6,173,064 $1,358,368

U.S. Department of Veteran Affairs 1 $18,737 $5,471

Total Federal Agencies 51 $9,086,788 $2,166,460 56 $6,930,207 $1,384,084 F&A = Facilities and Administrative Costs

Table 21: State Agencies Comparison FY 10/11 FY 11/12


Dept of Environmental Protection 1 $24,193 $4,839

Department of Health 7 $683,868 $75,603 3 $308,440 $39,604

Total Florida State Agencies 7 $683,868 $75,603 4 $332,633 $44,443 F&A = Facilities and Administrative Costs

24

Table 22: Corporations and Companies Comparison

FY 10/11 FY 11/12


Alnara Pharmaceuticals 1 $305 $61

AstraZeneca 2 $131,850 $37,550

Boehringer Ingelheim Intl GMBH 1 $100,000 $15,200 1 $6,800 $2,158

Clinical Research GMBH 1 $34,655 $3,150

FEFA INC 1 $309,202 $64,523

GlaxoSmithKline, Inc. 3 $122,174 $23,747 1 $30,759 $6,152

Golin-Harris Int'l., Inc. 1 $5,000 $1,000 1 $5,000 $1,000

Jacobus Pharmaceuticals 1 $73,371 $14,674 1 $192,043 $38,408

JMJ Technologies 1 $12,500 $2,500

Media Pharma GMB & CO KG 4 $70,296 $14,059 3 $110,421 $22,084

Merck - University of Texas 1 $57,475 $11,495

Micromedic Technologies 1 $38,500 $7,700

Novus International 1 $13,513 $2,703

Pfizer, Inc. 1 $200,000 $0

Phytolab GMBH & CO KG 1 $48,735 $9,747

Research Triangle Institute 1 $2,197 $200

Steigerwald Arzneimittelwerk 1 $14,988 $2,998

TKL Research 11 $183,022 $36,604 1 $5,750 $1,150

Watson Laboratories 7 $236,700 $47,340

Watson Pharmaceuticals 1 $87,060 $7,915

Wyle Laboratories 1 $6,151 $2,011

Total Corporations and Companies 28 $680,756 $126,643 23 $1,417,711 $249,486


Table 23: Foundations and Societies Comparison

FY 10/11 FY 11/12


American Assoc. Colleges of Pharmacy 1 $8,820 $0

American Cancer Society 1 $11,493 $1,916 1 $11,492 $1,915

Am. Foundation for Pharmaceutical Edu. 2 $12,000 $0 6 $19,500 $0

American Heart Association 1 $22,180 $0 1 $77,000 $7,000

American Pharmacists Association 1 $1,000 $0

CHDI Foundation 1 $28,271 $0

Cystic Fibrosis Foundation 1 $1,500 $0

Society for Women's Health Research 1 $49,700 $0

UF Foundation 1 $93,260 $0 1 $100,000 $0

University of Colorado 1 $7,107 $646 1 $6,850 $623

Total Foundations and Societies 8 $156,360 $2,562 13 $293,813 $9,538


Table 24: Other Comparison

FY 10/11 FY 11/12


Miscellaneous Donors 1 $300 $0 2 $2,200 $0

Multiple Sponsors 4 $13,755 $2,751 1 $7,200 $1,440

Total Other 5 $14,055 $2,751 3 $9,400 $1,440


25

Clinical Laboratory Income

The Infectious Disease Pharmacokinetics Laboratory at the University of Florida (IDPL) has a clinical and research focus

on the treatment of patients with serious infections. The lab, which opened in July 2009 and located in the College of Pharmacy,

is part of the Emerging Pathogens Institute. The IDPL serves as a national reference center for the determination of serum

concentrations for the antimycobacterial, antifungal, and anti-HIV drugs, as well as linezolid. The lab also measures vitamin D.

The IDPL provides therapeutic drug monitoring to physicians and their patients, and it provides research study support to

investigators, using high-performance liquid chromatography and gas chromatography.

The clinical lab, working in cooperation with the Shands Clinical Laboratory, is CLIA licensed and College of American

Pathologists (CAP) Certified. This year’s clinical income had a decrease of 7.2% (Table 25).

Table 25: Clinical Laboratory Income FY 10/11 FY 11/12

$424,492 $393,565

Licensing and Royalty Income

Through licensing and maintenance fees the College of Pharmacy generated a total of $175,967 in revenues during FY

11/12. These monies were distributed to the College as outlined in the UF IP distribution policy.

Graduate Student Research Activities

Ayad Ali, a graduate student in the Department of Pharmaceutical Outcomes and Policy, was awarded a complimentary one-

year membership and a $1,500 travel award from the International Society for Pharmacoepidemiology (ISPE) for his poster

entitled “Inhaled and Intranasal Corticosteroids and Behavioral and Psychiatric Problems: A Pharmacovigilance Analysis

using AERS Data” to attend the 27th

ISPE in Chicago, IL in August 2011. Ayad also received a $750 travel award from the

American Association of Pharmaceutical Sciences (AAPS) for his poster entitled “Outcomes of Late Corticosteroid

Withdrawal after Renal Transplantation in Patients Exposed to Tacrolimus and/or Mycophenolate Mofetil: A Meta-

Analysis of Randomized Controlled Trials” to attend the 2011 AAPS Annual Meeting in Washington, DC in October 2011.

He also received a $500 student travel award from AAPS for his poster entitled “Association of Omalizumab with

Arteriothrombotic Events: A Pharmacovigilance Analysis” to attend the 2012 AAPS National Biotechnology Conference in

San Diego, CA in May 2012. He also received a $250 travel award from the University of Florida’s Graduate Student

Council for his poster entitled “Assessing the Association of Omalizumab Use and Arteriothrombotic Events through

Spontaneous Adverse Event Reporting” to attend the 17th

International Society for Pharmacoeconomics and Outcomes

Research (ISPOR) International Meeting in Washington, DC in June 2012.

Daniela Conrado, a graduate student in the Department of Pharmaceutics working with Dr. Hartmut Derendorf, was awarded

a $1,000 honorarium, a certificate, and complimentary registration from the American College of Clinical Pharmacology

(ACCP) for her abstract entitled “Population Pharmacokinetics and Pharmacodynamics of Armodafinil: Effects on

Electroencephalogram and Alertness of Sleep-deprived Adults” to attend the 40th

Annual Meeting of the ACCP in Chicago,

IL in September 2011. In addition, at the ACCP meeting Daniela competed for and won the Wayne A. Colburn Memorial

Award in which she receives an additional $500. Daniela also received a plaque and complimentary registration from the

American Society Clinical Pharmacology and Therapeutics (ASCPT) Presidential Trainee Award for her abstract

entitled “Pharmacokinetic-Pharmacodynamic Modeling for Armodafinil: Effects on Alertness and Electroencephalogram

of Sleep Deprived Adults” to attend the 113th

Annual Meeting of the ASCPT in National Harbor, MD in March 2012. In

addition, she also received $1,000 honorarium, a certificate, and complimentary registration from the American College of

Clinical Pharmacology (ACCP) for her abstract entitled “Pharmacokinetic-Pharmacodynamic Modeling of the

Electroencephalogram Effect of Armodafinil: Correlation with Behavioral Alertness” to attend the 41st Annual Meeting of

the ACCP in Hollywood, FL in October 2012.

Xiaodi Feng, a graduate student in Pharmacodynamics working with Dr. Maureen Keller-Wood, was awarded a Pfizer

President's Presenter's Award by the Society of Gynecologic Investigation for her abstract "Cortisol Increases Activated

Caspase-3 in Conductive Cells in the Fetal Heart" presented at the meeting in San Diego, CA in March of 2012. The award

consisted of a $1,000 award and a plaque, and was recognized at a luncheon at the Annual Meeting of the Society.

26

Caitlin Knox, a graduate student in the Department of Pharmaceutical Outcomes and Policy working with Dr. Almut

Winterstein, was awarded a $6,500 fellowship from the American Foundation for Pharmaceutical Education (AFPE) for

her project entitled “Type II Diabetes in Pregnant Women: Prevalence, Drug Utilization and Outcomes of Women with Type

II Diabetes during Pregnancy”.

Rana Montaser, a graduate student in the Department of Medicinal Chemistry working with Dr. Hendrik Luesch, was awarded

a $600 travel award from the American Society of Pharmacognosy (ASP) Waqar Bhatti Student Travel Award for her

paper entitled “Chemistry and Biology of Novel Cyanobacterial Secondary Metabolites from Guam” to attend the 2012

International Congress on Natural Products Research meeting in New York City, NY in July 2012.

Lilibeth Salvador, a graduate student in the Department of Medicinal Chemistry working with Dr. Hendrik Luesch, was

awarded the 2012 Kilmer Prize which consists of a $300 travel award from the American Pharmaceutical Association

(APhA) and a $700 travel award from the American Society of Pharmacognosy (ASP) for her paper entitled “Novel Elastase

Inhibitors from Marine Cyanobacteria: Structural Diversity, Target-bound Crystal Structures and Cellular Effects” to the

2012 International Congress on Natural Products Research meeting in New York City, NY in July 2012.

Jonathan Schelfhout, a graduate student in the Department of Pharmaceutical Outcomes and Policy working with Dr. Teresa

Kauf, was awarded a $6,500 fellowship from the American Foundation for Pharmaceutical Education (AFPE) for his

project entitled “Medication Adherence during Treatment for the Hepatitis C Virus: Impact on Sustained Virologic

Response Rates, Patient Burden and Lifetime Costs”.

Wan Sun, a graduate student in the Department of Pharmaceutics working with Dr. Gunther Hochhaus, was awarded a $1,000

honorarium, a certificate and complimentary registration from the American College of Clinical Pharmacology (ACCP) for

her abstract entitled “Development of a Disease Model for Bipolar Disorder” to attend the 2012 ACCP Annual Meeting in San

Diego, CA in September 2012.

Professional Student Research Activities

As the understanding of the development of new pharmaceutical agents and streamlining the drug use process is an integral

part of a pharmacy student’s education, the College of Pharmacy offers a series of “Problems in Pharmacy” courses that

expose students to various aspects of the research process. Each department in the College offers a “Problems in Pharmacy”

course that is designed to specifically target their individual research areas. In addition to the “Problems in Pharmacy”

courses, professional students interested in research select faculty mentors and submit grant or fellowship applications to

outside funding agencies to support their research efforts. This year we had 2 professional students who secured extramural

funding.

Julie Foster, a professional student at the Gainesville campus, received a $1,000 scholarship from the 2012 American

Association of Colleges of Pharmacy (AACP) Walmart Scholars Program to cover registration and travel expenses for the

Teacher’s Seminar to the AACP Annual meeting in Kissimmee, FL in July 2012.

The College of Pharmacy is dedicated to increasing the number of professionally trained pharmacists to consider a career

in academic pharmacy and pharmaceutical/biomedical research. We have found that providing an environment for training of

PharmD students very early in their professional degree program has been successful in directing future graduates to careers

in research. In following, the College provided a 10-week, full-time paid summer internship of $4,500 to both first (1PD)

and second (2PD) year PharmD students. The recipients of the summer internships are:

Student Name Campus Mentor

Meghan Arwood Gainesville Dr. Rhonda Cooper-DeHoff

Alan Beers Gainesville Dr. Margaret James

Bryan Brinda Gainesville Dr. John Markowitz

Sarah Burbage Gainesville Dr. Julie Johnson

Alan Byard Gainesville Dr. Charles Peloquin

Jacqueline Byrd Gainesville Dr. Julie Johnson

Lori Carter Gainesville Dr. Tommy Smith & Dr. Debbie Wilson

Melissa Chudow Gainesville Dr. Richard Segal

Juan Hincapie-Castillo Gainesville Dr. Almut Winterstein

Kenneth Leonard Gainesville Dr. Michael Katovich

Megha Patel Gainesville Dr. John Markowitz

27

Student Name Campus Mentor

John Prybyski Gainesville Dr. Ken Sloan

Priya Thoguluva Gainesville Dr. Earlene Lipowski

Sarah Valentine Gainesville Dr. Abraham Hartzema

Erika Walters Gainesville Dr. James Taylor

Krista White Gainesville Dr. David Angaran

Janis Dolembo Jacksonville Dr. John Lima

Petra Estep Jacksonville Dr. John Lima

Ronald Granados Orlando Dr. Rhonda Cooper-DeHoff

Mai-Thao Nguyen Orlando Dr. Otto Phanstiel

Rosemary Persaud Orlando Dr. Greg Roth

Scott Allen St. Petersburg Dr. P.K. Burnette

Richard Aramini St. Petersburg Dr. Joanna Peris

Danielle Honein St. Petersburg Dr. Reginald Frye

Jared Mannen St. Petersburg Dr. Julie Johnson

Lauren Self St. Petersburg Dr. Javier Cuevas


28

U.S.-Thai Consortium Activities

History of the U.S.-Thai Consortium

Until FY 08/09 the Executive Associate Dean also acted as the College’s principal liaison for the U.S.-Thai Consortium,

then Dr. Earlene Lipowski, Professor in the Department of Pharmaceutical Outcomes and Policy, assumed the US-Thai

consortium liaison position. This initiative is a major international training agreement between all of the colleges of pharmacy

in the country of Thailand and selected pharmacy schools in the United States.

In 1993, the University of Florida College of Pharmacy, nine other U.S. Pharmacy Schools and the American Association

of Colleges of Pharmacy entered into an international agreement with all nine (at that time) Thailand Colleges of Pharmacy

which together designated the U.S.-Thai Consortium Agreement. Since 1993, two other Thai schools and four U.S. schools

have joined the Consortium.

The mission of this U.S.-Thai agreement is to provide Thai pharmacists (faculty at the various Thai pharmacy schools),

that are selected by a Royal Thai Government Panel, the opportunity for advanced professional (Pharm.D.) or graduate (Ph.D.)

study in programs in the selected U.S. pharmacy schools. In return, the Royal Thai government will pay all stipend and tuition

costs for these students for a period of five years and provide return favors for both professional students and faculty to visit

Thailand and become involved in post-graduate pharmacy education abroad. Furthermore, the initial agreement was for the

Thai government to support, and the U.S. colleges to educate, 100 Thai faculty members (i.e., approximately 10 students per

U.S. college) over the ensuing 10 years.

As part of the original charter, it was agreed that all parties would meet once a year to discuss the progress of the U.S.-

Thai Consortium. These annual meetings would be held in either Thailand or the U.S. on alternating years. The first meeting

was held in Bangkok, Thailand in 1994; at Purdue University in 1995; at Phuket, Thailand in 1996; in Baltimore, MD in 1997;

Chiang Mai, Thailand in 1998; Orlando, FL in 2000; Bangkok, Thailand in 2002; Chicago, IL in 2004; Bangkok, Thailand in

2007; Madison, Wisconsin in 2008; and Phuket, Thailand in 2011.

Current List of Thai and U.S. Schools of Pharmacy in the Consortium

Thailand United States

1. Chulalongkorn University

2. Mahidol University

3. Khon Kaen University

4. Srinakharinwirot University

5. Prince of Songkla University

6. Silpakorn University

7. Ubon Ratchathani University

8. Chiang Mai University

9. Naresuan University

10. Mahasarakarn University

11. Rangsit University

12. Walailak University

1. University of Florida

2. Purdue University

3. Ohio State University

4. University of Wisconsin

5. University of Arizona

6. University of Minnesota

7. University of Illinois – Chicago

8. University of Maryland - Baltimore

9. University of North Carolina – Chapel Hill

10. University of Kentucky

11. University of Texas – Austin

12. University of Washington

13. University of Utah

14. University of Iowa

15. American Association of Colleges of Pharmacy

11th

U.S.-Thai Pharmacy Education Consortium Meeting

The biennial meeting of the U.S. – Thai Pharmacy Consortium was held June 1-4, 2011 in Phuket, Thailand with Prince of

Songkla University serving as the host institution.

There have been no new activities with the U.S.-Thai Consortium in the past year. Informal reports are that the Consortium

will meet next May in Baltimore, hosted by the University of Maryland. There is no official confirmation of a date. Dr.

Lipowski volunteered to serve on the planning committee for that meeting but has not had any further communication with the

steering committee.

Dr. Lipowski offered an APPE elective in International Health for 4 students during the month of June. Funding for this

was provided by a Faculty Enhancement Opportunity Award from UF and a complete report from Dr. Lipowski is available

upon request for those interested.

29

Thai Students in the College of Pharmacy

Listed below (Table26) is the Thai student enrolled during FY 11/12, although she is not the recipient of the Royal

Thai Scholarship from her government to study abroad for her Ph.D. degree.

Table 26: Thai Students

Name Department THAI Pharmacy College Date Entered

Metavarayuth, Kamolrat * Medicinal Chemistry Chulalongkorn University FY 10/11

* not a Royal Thai Scholar


30

ORGS Coordinated Events

Two major COP functions are coordinated by the ORGS, the Post-baccalaureate Reception and the Annual Research

Showcase and Awards Recognition Day. These events are described below.

Post-baccalaureate Reception

The annual Post-baccalaureate Reception is held at the beginning of the Fall Semester as an event to introduce all new

faculty, graduate students, post-doctoral fellows and research associates to the COP community. This year the event was held

on Wednesday, September 14, 2011, in the Grand Ballroom at the Reitz Student Union from 6:00 PM to 8:00 PM. This year we

had 141 faculty, staff and students. At the reception this year 12 new graduate students, 6 new faculty members, and a number

of new post-doctoral fellows, research associates and visiting scientists were introduced to the college.


The 25th

Annual Research Showcase and Awards Recognition Day took place on Thursday, February 16, 2012, at the

University of Florida, College of Pharmacy. A program booklet (Appendix C) is included that outlines the day’s events, a

complete list of competitors for each of the divisions and the judges for each of the events.

This year’s Showcase and Awards Recognition Day could not have taken place without the financial backing of our many

sponsors. Our major sponsors this year were Dr. Robert G. and Maria Bell (Ph.D. class of 1988) through Drug &

Biotechnology Development, LLC, Palm Harbor, FL; and Dr. James Talton (Ph.D. class of 1999) through Nanotherapeutics,

LLC, Alachua, FL. Other longtime supporters were Dr. Maureen McKenzie through DENALI BioTechnologies, Inc.,

Soldotna, Alaska; and Dr. Robert A. and Phyllis Levitt (Ph.D. class of 1961) of Boca Raton and Gainesville, FL sponsoring

the Levitt Division of the Oral Competition. For a complete list of our sponsors please refer to the program booklet.

The Showcase and Awards Recognition Day is full of excitement and discovery, as graduate students, pharmacy students

and post-doctoral fellows from throughout the College compete (via posters and platform presentations) for the distinction of

being the “best” in one of the following categories:

Oral Competition Poster Competition

Senior Graduate Division

Junior Graduate Division

Levitt Division

Post-doctoral Fellow Division

Pharmacy Student Division

Graduate Student Division

The finalists for the oral competition divisions submitted competitive abstracts that were reviewed and selected by the

Graduate Studies Committee within the College. The Senior Graduate Division of the Oral Competition applies to those

graduate students who are in the final stages of their graduate education. The Junior Graduate Division pertains only to

graduate students who are in the first two years of their graduate program. The Levitt Division was established in 1993 to

recognize those graduate students who are doing graduate work related in the areas of health outcomes research or related

translational research in the clinical sciences.

The finalists in each of the oral divisions give a 12-15 minute presentation followed by a 3-5 minute question/answer

period. Based on the student’s abstract and their presentation, a winner in each division is selected by a panel of judges.

Winners receive a $600 cash award and commemorative plaque. Each of the finalists receives a $300 cash award and a

commemorative plaque.

Judges for the oral competition were: Dr. Maureen McKenzie, Chief Executive Office, DENALI BioTechnologies, Inc.;

Dr. Maria Miralles, Senior Pharmaceutical Management Advisor, United States Agency International Development (USAID);

Dr. Robert Navarro, Clinical Professor, Department of Pharmaceutical Outcomes and Policy, College of Pharmacy; and Dr.

Larry Lopez, Emeritus Professor, Department of Pharmacotherapy & Translational Research, College of Pharmacy.

The winners of the oral competition are:

Senior Division – winner

Daniela Conrado Pharmaceutics $600 cash award

Title: “Pharmacokinetic-Pharmacodynamic Modeling of Armodafinil: Effects on Electroencephalogram and Neurocognition

of Sleep Deprived Adults”

Senior Division – finalists

Yue Liu Pharmacodynamics $300 cash award

Title: “Involvement of Mitochondrial Complexes in Divalent Manganese-stimulated Release of Hydrogen Peroxide

in Microglial Cells”

31

Rui Wang Medicinal Chemistry $300 cash award

Title: “Biological Mode of Action Study of a Small Molecule Inducer of the Antioxidant Response Element”

Junior Division – winner

Rana Montaser Medicinal Chemistry $600 cash award

Title: “Drugs from the Sea: Chemical and Biological Characterization of Novel Fatty Acid Derivatives from the Guamanian

Marine Cyanobacteria Lyngbya spp.”

Junior Division – finalists

Bhargava Kandala Pharmaceutics $300 cash award

Title: “Design and Analysis of Pharmacodynamic Crossover Studies Conducted to Establish Bioequivalence of Inhaled

Corticosteroids”

Lilibeth Salvador Medicinal Chemistry $300 cash award

Title: “Novel Bioactive Natural Products from the Marine Cyanobacterium Symploca sp. as Leads for Drug Discovery”

Levitt Division – winner

Steven Bird Pharmaceutical Outcomes and Policy $600 cash award

Title: “Risk of Venous Thromboembolism with Drospirenone: A Population-based Comparative-safety Study”

Levitt Division – finalist

Efe Eworuke Pharmaceutical Outcomes and Policy $300 cash award

Title: “Drug Utilization Patterns for Routine Therapies in Patients with Cystic Fibrosis”

For the poster competition this year we had 31 posters from graduate students, professional students and post-doctoral

fellows on display in the Reception Area of the Health Profession, Nursing and Pharmacy Building (HPNP). The posters were

manned between 9:30 AM and 11:30 AM when individual judging took place. The winners in each of the divisions received a

$300 cash award and a commemorative plaque.

The poster judges were: Dr. Abdolreza Davoodi-Semiromi, Research Assistant Professor, Department of

Pharmacotherapy & Translational Research, College of Pharmacy; Dr. Eric Krause, Assistant Professor, Department of

Pharmacodynamics, College of Pharmacy; Dr. Larry Lesko, Professor, Center for Pharmacometrics & System Pharmacology,

College of Pharmacy; Dr. Michael Philbin, Senior Clinical Science Manager, Abbott; Dr. Teresa Roane, Clinical Assistant

Professor, Department of Pharmacotherapy & Translational Research, College of Pharmacy; Dr. Stephan Schmidt, Assistant

Professor, Center for Pharmacometrics & System Pharmacology, College of Pharmacy.

The winners of the poster competition are:

Graduate Student Division – winners

Mong-Jen Chen Pharmaceutics $300 cash award

Title: “A Novel Approach of Regenerative Medicine for the Treatment of Alpha 1 Antitrypsin Deficiency”

Krishnakanth Kondabolu Medicinal Chemistry $300 cash award

Title: “Preclinical Antipsychotic Efficacy of Novel Phenylaminotetralin (PAT) Analogs Acting at Serotonin 5-HT2 Receptors”

Professional Student Division – winner

Joseph Pardo Shands at the University of Florida $300 cash award

Title: “Analysis of the Time-to-Positivity of Blood Cultures at a Tertiary Care Hospital: Antimicrobial Stewardship

Implications”

Post-doctoral Fellow Division – winner

Caitrin McDonough Pharmacotherapy and Translational Research $300 cash award

Title: “Non-synonymous SNPs in SELE, SELP, and SIGLEC12 Associated with Cardiovascular (CV) Outcomes in the

INternational VErapamil SR-Trandolapril STudy GENEtic Substudy (INVEST-GENES)”


32

Other ORGS Activities

In addition to the two major functions coordinated by the ORGS (Post-baccalaureate Reception and the Annual Research

Showcase and Awards Recognition Day) other activities were performed or attended by ORGS personnel as outlined below.

Committee Assignments

The Executive Associate Dean served on various College, Health Science Center and University Committees throughout

the academic year.

Critical this year was the Executive Associate Dean’s role on the committee involved in the design and planning of the

new University of Florida Research and Academic Center (UFRAC) at Lake Nona, Florida. The UF Research and Academic

Center opened in the Summer of 2012 and features three main components critical to the College’s mission that are outlined in

the recent review by Linda Homewood, News and Communications Director in the College of Pharmacy:

Lake Nona Update - The University of Florida Research and Academic Center Orlando_July2012.docx

COLLEGE COMMITTEES

Executive Council: This committee met each month throughout the year to discuss relevant issues related to the daily

operations of the College and long-range planning. Chaired by the Dean of the College, this committee is integral to

assisting the Dean in making decisions on major initiatives in the College.

Graduate Studies Committee: Please see Graduate Education and Program Activities; Graduate Studies

Committee (GSC) Activities for details and activities of this committee throughout the year.

College Research Committee: The Executive Associate Dean serves as chair of the College Research Committee. The

research committee was established to prepare a written policy document on allocation and reallocation of research and

office space, as well as, critical review and direction of all research activities in the College. The committee is also a

decision making committee on “limited application programs”. Sponsors are restricting the number of applications an

institution can submit in response to many funding opportunities. The Research Committee will be involved in

selecting the proposal (or proposals) that will be submitted in response to a limited application program back to

the Division of Sponsored Research for selection at the University level. The Committee also selects college

finalists for the various research awards offered through the University.

Faculty Governance Council: The Executive Associate Dean serves as a non-voting ex-officio member of the Faculty

Governance Council. The Faculty Governance Council (FGC) is comprised of faculty and college administration, who

together make policies relevant to the faculty. The FGC met nine times this past year.

HEALTH SCIENCE CENTER (HSC) COMMITTEES

HSC Research Dean’s Group: This committee met monthly throughout the year to discuss relevant issues related to both

basic and clinical research within the HSC and University.

Anatomical Specimen Task Force: This committee met twice throughout the year to consider current and future policies

and use of cadavers and human specimens within the HSC teaching facilities.

HSC Traffic and Parking Task Force: This committee met four times throughout the academic year to consider issues

and establish policies related to parking and traffic patterns in and around the HSC.

UNIVERSITY COMMITTEES

Council of Graduate Deans: This committee met once per semester during the academic year and was entrusted with

making recommendations on major initiatives related to graduate education. The chair of this committee was Dr. Kenneth

Gerhardt, Associate Dean for Graduate Programs.

Land Use Facilities Planning Committee: The Executive Associate Dean d this past year served as the Chair of the

Committee. This committee met monthly to provide recommendations to UF entities related to policies related to UF land

use and facilities development. The breadth of this committee considered the land use for new building sites as well as

Lake%20Nona%20Update%20-%20The%20University%20of%20Florida%20Research%20and%20Academic%20Center%20Orlando_July2012.docx

http://www.cop.ufl.edu/millard/copcommittees/Executive%20Council/Index.htm

http://www.cop.ufl.edu/millard/copcommittees/GSC%20Meetings/Index.htm

http://www.cop.ufl.edu/millard/copcommittees/Space%20Committee/Index.htm

http://www.cop.ufl.edu/millard/copcommittees/FGC%20Meetings/Index.htm

http://www.aa.ufl.edu/committees/lufpc.asp

33

planning for proposed renovation of existing buildings. Our charge was to also assist in the development and updating of

the UF Master Plan related to land and building use.

Academic Infrastructure Council: As chair of the Land Use and Facilities Planning Committee the Executive Associate

Dean is also a member of the Senate’s Academic Infrastructure Council. This council's area encompasses the University's

infrastructure supporting the University's academic mission, including the provision of physical facilities and other physical

resources; libraries; information technology; the campus master plan; and the availability of adequate computer, classroom,

laboratory and other resources. This Committee met monthly throughout the Fall and Spring Semesters of 2011-2012.

Conferences Attended Related to ORGS and COP Activity

COP National Advisory Board: The Executive Associate Dean attended the Fall 2011 (September) and Spring

2012(April) National Advisory Board Meetings.

AACP Interim Meeting: The Executive Associate Dean attended the 2012 AACP Interim Meeting in San Diego, CA,

from February 11th

to February 15th

, 2012.

AACP Annual Meeting: The Executive Associate Dean attended the 2012 AACP Annual Meeting in Kissimmee, FL,

from July 14th

to July 18th

, 2012.

NCURA Departmental Research Administration Workshop: The Grants Specialist and the Sr. Grants Specialist

attended the NCURA DRA Workshop held on campus from September 19th

to September 21st, 2011.

SRA International Meeting: The Grants Specialist attended the 2011 Annual Society of Research Administrators (SRA)

International Meeting in Montréal, Canada from October 23rd

to October 26th

, 2011.


http://www.senate.ufl.edu/councils/infrastructure/

34

Appendices

Section

A = Letter to Graduate Applicants

B = Complete Listing of Extramural Support by Department and Faculty

C = 25th

Annual Research Showcase and Awards Recognition Day Booklet


35

College of Pharmacy 101 S. Newell Drive, HPNP Building, Room 4320 Office of Research and Graduate Studies PO Box 100484, Gainesville, FL 32610 Ph: 352-273-6308, Fax: 352-273-6306 Dear Applicant:

Thank you for your interest in graduate education in the College of Pharmacy at the University of Florida. The College of Pharmacy

currently has four major areas of graduate concentration. These areas include Medicinal Chemistry, Pharmaceutics, Pharmacodynamics

and Pharmaceutical Outcomes and Policy. In your letter you did not indicate which graduate area(s) of study you are interested in.

We ask at this time that you please specify your area of research concentration. In doing this you would certainly expedite the application

process and minimize the receipt of extra information about areas of research you have no interest in.

All College of Pharmacy graduate programs can be accessed on the World Wide Web (http://www.cop.ufl.edu). Using the WWW you

would get a comprehensive review of the underlying theme of each of our graduate programs as well as the faculty and their research

interests. Furthermore, you can download all application and admission forms for graduate study at the University of Florida from this web

site. I strongly encourage you to utilize this source of information (WWW), as this is your most efficient mechanism to apply to one or

more of the graduate programs in the College of Pharmacy.

In the event that you do not have access to the WWW, listed below is each of the Graduate Programs in the College of Pharmacy. We have

included a short overview of the area of graduate concentration with the name, address, phone number and e-mail address of the respective

graduate coordinator.

Graduate Program in Medicinal Chemistry

Medicinal Chemistry is a unique blend of the physical and biological sciences. The scope of the field is sufficiently broad to give students

with many different science backgrounds a rewarding and challenging program of study. Areas of active research include natural products,

chemistry, drug delivery systems, organic synthesis of medicinal agents, metal chelate design, drug metabolism, molecular toxicology,

molecular biology, analytical and forensic chemistry, molecular modeling and drug discovery. The department has excellent facilities for

research in the major areas of Medicinal Chemistry and faculty have been highly successful in attracting extramural research support for the

past several years.

Graduate Coordinator: Dr. Raymond Bergeron

Department of Medicinal Chemistry

PO Box 100485

College of Pharmacy, University of Florida

Gainesville, Florida 32610-0485

(352) 273-7726, E-mail: [email protected]

Graduate Program in Pharmaceutics

Research in the Pharmaceutics Department encompasses basic, applied, and clinical investigations in (i)

pharmacokinetics/biopharmaceutics, (ii) pharmaceutical analysis, (iii) pharmaceutical biotechnology and drug delivery. In addition to

teaching, all faculty members are involved in collaborative research projects with clinical and other basic scientists with the Health Center

or on campus. Many maintain collaborative ties with scientists in other universities and the pharmaceutical industry worldwide.

Graduate Coordinator: Dr. Tony Palmieri

Department of Pharmaceutics

PO Box 100494




Training Program in Clinical Pharmaceutical Sciences

The Clinical Pharmaceutical Sciences training program is a collaborative effort between the Departments of Pharmacotherapy &

Translational Research and Pharmaceutics. The goal of the Clinical Pharmaceutical Sciences training program is to prepare

motivated individuals to pursue independent research careers in academia, industry, or government. The current research focus

of the program is on understanding genetic and non-genetic factors that contribute to variability in drug response. Selected areas

of research include cardiology, infectious disease, asthma/pulmonary, psychiatry, and clinical pharmacology/drug metabolism.

http://www.cop.ufl.edu)/

mailto:[email protected]


http://www.cop.ufl.edu/departments/PP/index.htm

http://www.cop.ufl.edu/departments/PP/index.htm

http://www.cop.ufl.edu/departments/PC/index.htm

36

Students in the program conduct hypothesis-driven clinical research that includes a strong laboratory element. Excellent

research facilities are available including state-of-the art bioanalytical and pharmacogenomics laboratories, and an NIH-funded

Clinical and Translational Science Institute for clinical study conduction.

Graduate Coordinator: Dr. Reginald F. Frye

Department of Pharmacotherapy & Translational Research

Box 100486




Graduate Program in Pharmaceutical Outcomes and Policy

Drug therapy is the most widely used and efficacious treatment modality available for a variety of health disorders. However, problems

(inappropriate prescribing, inadequate monitoring, and misuse of medication) with medication use are persistent and costly. Research and

course of study in the Department of Pharmaceutical Outcomes and Policy focuses on various issues related to societal use of medications

and include (i) estimating costs of drug-related morbidity and mortality, (ii) evaluating the prescribing process, medication use and related

health care activities and, (iii) examining ways to improve prescribing and use of medications in various health care systems.

Graduate Coordinator: Dr. Almut Winterstein

Department of Pharmaceutical Outcomes and Policy

PO Box 100496




Graduate Program in Pharmacodynamics

The purpose of the graduate program in Pharmacodynamics is to develop biomedical scientists with a broad knowledge in the areas of

Physiology, Pharmacology, Endocrinology and Toxicology. Although the research interests of the faculty are broad, there is an emphasis

on the holistic approach to drug actions in living systems. The Department has strong programs in the areas of cardiovascular, reproductive

and neuroendocrine physiology and pharmacology, temperature regulation, neurobiology of aging, autonomic pharmacology, and

neuropharmacology.

Graduate Coordinator: Dr. Joanna Peris

Department of Pharmacodynamics

PO Box 100487




Please direct any future questions or request for application materials concerning the area of study you are interested in to the graduate

coordinator of the respective department listed above.

If we can be of further assistance to you please call us at (352) 273-6301. Again, thank you for your interest in our college at the

University of Florida. We look forward to hearing from you and eventually, receiving your application forms.

Respectfully, Respectfully,

William J. Millard, Ph.D. José Ortiz

Executive Associate Dean Office Assistant

University of Florida University of Florida

College of Pharmacy College of Pharmacy


https://www.ctsi.ufl.edu/




37

Complete Listing of Extramural Support in the COP for FY 11/12

MEDICINAL CHEMISTRY

Faculty Amount Number Agency Project Title

Raymond Bergeron $625,942 1 National Institute of Health Iron Chelators Predicated on Desferrithiocin

Raymond Booth $172,795 1 National Institute of Health Novel Functionally-selective Serotonin 5HT2 Drugs for Amphetamines

Abuse/Disorders

$231,282 1 National Institute of Health Serotonin 5HT2C Agonist Drugs with 5HT2A/SB Antagonist Activity

Margaret James $24,193 1 University of South Florida Effect of Deepwater Horizon Oil Spill on Fish Communities

$50,682 1 National Institute of Health Fetal Endocrine Disruption by Tryclosan

$37,261 2 National Institute of Health Seafood Hydrocarbon Residues & Coastal Community Health Risks (Project 3)

Hendrik Luesch $202,454 1 Florida Department of Health Chemistry and Biology of Apratoxins

$51,151 1 National Institute of Health Mitochondrial Oxidative Stress in the Retinal Pigment Epithelium as a Model for

Atrophic Macular Degeneration

Kenneth Sloan $105,352 1 University of Colorado Transcleral Therapeutics in Diabetic Retinopathy

38

PHARMACEUTICS


Veronika Butterweck $4,542 1 National Institute of Health Herb-drug Clucuronidation Interactions

Hartmut Derendorf $6,800 1 Boehringer Ingelheim Intl GMBH Comparative Dissolution Study of Commercial Telmisartan Tablets

$6,500 2 American Foundation for

Pharmaceutical Education

Use of Dermal Microdialysis to Evaluate the Effect of Skin Properties and Application

Site on the Topical Bioequivalence of Diclofenac

$5,000 1 Golin-Harris International Inc. Grapefruit-Drug Interactions

$131,850 2 Astrazeneca In vitro PK/PD Investigations of Beta-Lactam/Beta-Lactamase-Combinations for the

Treatment of Infections caused by Multidrug Resistant Gram-negative Bacteria

$200,000 1 Pfizer, Inc. Pfizer Graduate Fellowship Award

Guenther Hochhaus $28,271 1 CHDI Foundation Development of Disease Progression Models for Huntington's Disease

$1,200 1 Miscellaneous Donors Miscellaneous Donors

$309,202 1 FEFA INC Pharmacokinetic Comparison of Locally Acting Inhaled Drug Products

$87,060 1 Watson Pharmaceuticals Stability of Methacholine Solutions at Room Temperature

Sihong Song $6,850 1 University of Colorado Structure Guided Small Molecule Targeting of Anti-insulin Primary Trimolecular

Complexes

39

PHARMACODYNAMICS


Jason Frazier $183,125 1 National Institute of Health CB1R Independent Effects of Cannabinoids on Synaptic Physiology in the CNS

$100,000 1 University of Florida Foundation The Role of Calcium Activated Potassium Channels in Geriatric Memory Dysfunction

Michael Katovich $272,041 2 National Institute of Health Angiotensin-Converting Enzyme2 in Vascular Endothelial Function

$191,754 2 National Institute of Health CVD Protection Mechanisms Involving ACE2/ANG-(1-7)

Maureen Keller-Wood $120,015 2 National Institute of Health Corpus Luteal Contribution to Maternal Pregnancy Physiology and Outcomes in Art

$238,777 2 National Institute of Health Effects of Maternal Cortisol on Fetal and Neonatal Growth and Metabolism

$13,874 1 National Institute of Health Fetal Endocrine Disruption by Tryclosan

$28,164 2 National Institute of Health Glucocorticoids, Stress and Blood Pressure Regulation

$13,722 1 National Institute of Health Paraventricular Nucleus Regulatory Mechanisms in Stress and Hypertension

$21,956 1 National Institute of Health Renal Transporters and Fetal Neuroendocrinology

$227,595 1 National Institute of Health The Baroreflex in Pregnancy: Effects of Adrenal and Placental Steroids

Eric Krause $248,999 1 National Institute of Health Central Angiotensin Receptors and the Neural Control of Homeostasis

Vinayak Shenoy $77,000 1 American Heart Association Therapeutic Role of ACE2 in Pressure-overload Induced Right Ventricular Dysfunction

and Failure

40

PHARMACEUTICAL OUTCOMES AND POLICY


Chris Delaney $34,848 1 University of Washington Comparative Effectiveness of Lipid Lowering and Antihypertensive Medications among

Patients Infected with HIV

Teresa Kauf $30,759 1 GlaxoSmithKline The Burden of Hepatitis C-related Thrombocytopenia: Evidence from National Health

& Wellness Survey and Thrombocytopenia Survey

Folakemi Odedina $10,340 1 National Institute of Health Cancer Advocacy for African Countries

$65,986 1 Florida Department of Health Florida Community Health Workers Effectiveness Project

$1,000 1 Miscellaneous Donors Miscellaneous Donors

Richard Segal $6,500 2 American Foundation for


Increasing Community Pharmacists Smoking Cessation Counseling Rate through

Professional Moral Engagement

Almut Winterstein $192,650 1 Florida Medical Quality Assurance Agreement between Florida Medical Assurance, Inc., and the Board of Trustees

$25,379 1 Rutgers State University Developing Evidence to Inform Decisions about Effectiveness Research Network

$6,500 2 American Foundation for


Type II Diabetes in Pregnant Women: Prevalence, Drug Utilization and Outcomes of

Women with Type II Diabetes during Pregnancy

$539,114 1 Food and Drug Administration Pharmaceutical Outcomes and Policy Training Program for Health Science Graduates

41

PHARMACOTHERAPY & TRANSLATIONAL RESEARCH


Rhonda Cooper-DeHoff $49,700 1 Society for Women's Health Research Sex-specific Genetic Variability in Mechanistic Pathways and Cardiovascular

Outcomes in Women with Non-obstructive Coronary Artery Disease

$29,139 1 Wake Forest University Women's Health Initiative Extension 2010-2015

Reginald Frye $242,392 2 National Institute of Health Herb-drug Clucuronidation Interactions

$11,492 1 American Cancer Society Mechanisms Predicting Pain Trajectory among Cancer Patients

Leslie Hendeles $5,750 1 TKL Research A Multi-center, Randomized, Double-blind, Five-way Crossover, Pharmacodynamic

Study Comparing Perrigo's Albuterol Inhalation Aerosol to Teva's ProAir HFA

Inhalation Aerosol using a Methacholine Challenge Design in Asthmatic Patients

$236,700 7 Watson Laboratories Double-blind, Double-masked, Randomized, Placebo-controlled, Cross-over Study of

the Bronchoprotective Effect of Generic Levalbuterol Tartrate HFA & Xopenex HFA

Metered-dose Inhaler Formulations against Methacholine-induced Bronchoconstriction

in Asthmatic Subjects

$110,421 3 MEDA Pharma GMBH & CO KG Relative Potency of Formoterol Novolizer 12 mcg Compared to Formoterol Aerolizer

12 mcg in Patients with Stable Asthma using a Bronchoprovocation with Methacholine

as a Bioassay

Julie Johnson $58,825 9 University of Pennsylvania Clarification of Optimal Anticoagulation through Genetics (COAG)

$29,984 1 Ohio State University Expression Genetics in Drug Therapy (AIMS 3-5)

$1,780,582 1 National Institute of Health Pharmacogenomic Evaluation of Antihypertensive Responses

$87,900 1 University of Maryland Pharmacogenomics of Anti-platelet Interventions-2 (PAPI2) Study

$708,555 2 National Institute of Health Secondary Prevention of Subcortical Stroke Prevention Genetic Substudy

$130,230 2 National Institute of Health UF Clinical and Translational Science Award

$7,425 1 Cedars Sinai Medical Center Women’s Ischemia Syndrome Evaluation (WISE) Coronary Vascular Dysfunction

42

PHARMACOTHERAPY & TRANSLATIONAL RESEARCH (cont.)


Taimour Langaee $6,151.00 1 Wyle Laboratories Genotyping Analysis

$38,500 1 Micromedic Technologies Pharmacogenetic and Clinical Predictors of Bisphosphonate-associated Osteonecrosis

of the Jaw (ONJ)

John Markowitz $97,678 1 National Institute of Health Genetic Variants of Human Carboxylesterase 1 Influence the Activation and Antiviral

Activity of Oseltamivir

Charles Peloquin $192,043 1 Jacobus Pharmaceutical A Pharmacokinetic Study of 3,4 DAP in Healthy Volunteers

$7,200 1 Multiple Sponsors Multiple Sponsors

$74,495 3 Rhode Island Hospital Pharmacogenetics and Drug-Drug Interactions During HIV and TB Therapy

$18,117 1 Harvard University Randomized Trial of High-dose Rifampin

$57,475 1 Merck - University of Texas The Effect of Rifapentine on Plasma Concentrations of Raltegravir

$23,525 1 Case Western Reserve University Tuberculosis Research Unit (TBRU)

Karen Sando $40,000 1 Florida Department of Health AHEC Tobacco Training and Cessation Program

Kristen Weitzel $1,000 1 American Pharmacists Association Use of an iPad with Electronic Medical Record Software to Facilitate Patient Care in a

Pharmacist-run Ambulatory Care Clinic


43

25th

ANNUAL RESEARCH

SHOWCASE AND AWARDS

RECOGNITION DAY

THURSDAY, FEBRUARY 16

th, 2012

UNIVERSITY OF FLORIDA

COLLEGE OF PHARMACY

A SPECIAL THANKS TO THIS YEAR’S SPONSORS

PLATINUM SPONSOR

Drug & Biotechnology Development, LLC

Clearwater, FL

Dr. Robert G. and Maria Bell; Class of 1988

Nanotherapeutics, Inc.

Alachua, FL

Dr. James Talton; Class of 1999

Poster Competition Sponsor

GOLD SPONSORS

DENALI BioTechnologies, LLC

Soldotna, AK

Dr. Maureen McKenzie

Dr. Robert A. and Phyllis Levitt

Gainesville, FL; Class of 1961

Levitt Division, Oral Competition Sponsor

Dr. David W. Newton

Winchester, VA; Class of 1976

Debbie Klapp - Memorial Endowment

SILVER SPONSORS

Dr. Gwen (Victoria) De Leon

Orange Park, FL; Class of 1994

with matching gift from Publix

Dr. Yan Gong

Gainesville, FL; Class of 2004

Dr. Christian Hampp

Baltimore, MD; Class of 2009

Dr. H. Thomas Karnes

Richmond, VA; Class of 1984

Dr. Teresa Kauf

Gainesville, FL; Faculty

SPONSORS Dr. Raymond Jurgens

Madison, WI; Class of 1973

Dr. James Sacco

Madison, WI; Class of 2006

44

SCHEDULE OF EVENTS

8:00am - 9:00am Set-up Poster Presentations (Reception Hall, HPNP Building)

POSTER COMPETITION

9:00am - 11:30am Poster Competition – Students Present for Judging

(Reception Hall, HPNP Building)

ORAL COMPETITION

1:00pm - 1:10pm Introduction – Dr. Teresa Kauf, Associate Professor,

Pharmaceutical Outcomes and Policy (Room G-101, HPNP

Building)

Levitt Division (20 minute presentations)

1:10pm - 1:30pm Steven Bird

1:30pm - 1:50pm Efe Eworuke

Junior Division (15 minute presentations)

1:55pm - 2:10pm Bhargava Kandala

2:10pm - 2:25pm Rana Montaser

2:25pm - 2:40pm Lilibeth Salvador

2:40pm - 2:50pm BREAK

Senior Division (20 minute presentations)

2:55pm - 3:15pm Daniela Conrado

3:15pm - 3:35pm Yue Liu

3:35pm - 3:55pm Rui Wang

4:00pm - 5:15pm Keynote Address Maria Miralles, PhD, Senior Pharmaceutical

Management Advisor, United States Agency International Development

(USAID), “Pharmaceuticals in the Global Health Research Agenda: A

Donor’s Perspective” (Room G-114, HPNP Building)

5:15pm - 7:00pm Awards Reception – Refreshments and Announcement of

Winners (Reception Hall, HPNP Building)

ORAL COMPETITION

LEVITT DIVISION

#1 Presenter: Steven Bird


Research Title: Risk of Venous Thromboembolism with Drospirenone: A Population-

based Comparative-safety Study

#2 Presenter: Efe Eworuke


Research Title: Drug Utilization Patterns for Routine Therapies in Patients with Cystic

Fibrosis

JUNIOR DIVISION

#1 Presenter: Bhargava Kandala


Research Title: Design and Analysis of Pharmacodynamic Crossover Studies

Conducted to Establish Bioequivalence of Inhaled Corticosteroids

#2 Presenter: Rana Montaser


Research Title: Drugs from the Sea: Chemical and Biological Characterization of Novel

Fatty Acid Derivatives from the Guamanian Marine Cyanobacteria

Lyngbya spp.

#3 Presenter: Lilibeth Salvador


Research Title: Novel Bioactive Natural Products from the Marine Cyanobacterium

Symploca sp. as Leads for Drug Discovery

SENIOR DIVISION

#1 Presenter: Daniela Conrado


Research Title: Pharmacokinetic-Pharmacodynamic Modeling of Armodafinil: Effects

on Electroencephalogram and Neurocognition of Sleep Deprived Adults

#2 Presenter: Yue Liu


Research Title: Involvement of Mitochondrial Complexes in Divalent Manganese-

stimulated Release of Hydrogen Peroxide in Microglial Cells

#3 Presenter: Rui Wang


Research Title: Biological Mode of Action Study of a Small Molecule Inducer of the

Antioxidant Response Element

45

POSTER COMPETITION

# 1 Modulation of Voluntary Alcohol Consumption by 5-HT2A/C Receptor Subtypes: A

Promising Target for Treating Alcoholism

Presenter: Richard Aramini and Sarah Bisceglia (Pharmacodynamics/Professional

Students)

Authors: R Aramini, S Bisceglia, R Tikamdas, P Cogan, K Chen Yin, J Kasper, M

Kim, C Canal, R booth, J Peris

# 2 Retrospective Study of Drotrecogin Alpha (Activated) Use in Burn Patients

Presenter: Kristi Beermann (Shands, University of Florida/Professional Student)

Authors: K Beermann, A LeClaire, N Ladikos, D Mozingo

# 3 A Discriminative Analytical Method for Detection of CES1A1 and CES1A2/CES1A3

Genetic Variants

Presenter: Bryan Brinda (Pharmacotherapy & Translational Research/Professional

Student)

Authors: H Zhu, B Brinda, J Markowitz

# 4 Educational Interventions Targeting Students of Health Care Disciplines to Improve

Cultural Competencies Specific to Caring for People with Disabilities

Presenter: Lori Carter (Pharmaceutical Outcomes & Policy/Professional Student)

Authors: L Carter, D Wilson, WT Smith

# 5 Impact of Computerized Physician Order Entry (CPOE) on the Safety of Patient-

controlled Analgesia

Presenter: Caitlin Dickens (College of Medicine, Department of Anesthesiology/

Professional Student)

Authors: C Dickens, J Waldfogel

# 6 Ototopical Neomycin Exposure in Children with Non-intact Tympanic Membranes

Presenter: Juan Hincapie-Castillo (Pharmaceutical Outcomes & Policy/Professional

Student)

Authors: J Hincapie-Castillo, A Winterstein, P Antonelli, P Kubilis, D Xu

# 7 The Effects of Dietary Polyunsaturated Fatty Acids on Pain Response in Third

Molar Surgery Patients

Presenter: Danielle Honein (Pharmacotherapy & Translational Research/Professional

Student)

Authors: D Honein, B Hastie, M Stavropoulos, M Wallace, R Frye

POSTER COMPETITION (cont.)

# 8 Analysis of the Time-to-Positivity of Blood Cultures at a Tertiary Care Hospital:

Antimicrobial Stewardship Implications

Presenter: Joseph Pardo (Shands, University of Florida/Professional Student)

Authors: J Pardo, K Klinker, S Borgert, G Trikha, R Ramphal

# 9 Drug-associated Health Outcomes of Interest: A Systematic Review of Published

Literature

Presenter: Sarah Valentine (Pharmaceutical Outcomes and Policy/Professional Student)

Authors: S Valentine, A Hartzema

# 10 A Novel 5-HT2C Agonist/5-HT2A Antagonist Attenuates the Increase in Voluntary

Ethanol Consumption Seen After a Period of Alcohol Deprivation in Rats

Presenter: Joshua Winegar (Pharmacodynamics/Professional Student)

Authors: J Winegar, C Doyle, A George, K MacFadyen, J Kasper, M Kim, C Canal, R

Booth, J Peris

# 11 Immunization Error Rate With and Without the Use of a Standardized Order Set in

an Ambulatory Pediatric Clinic Using a Computerized Physician Order Entry

System

Presenter: Carolyn Smith (Pharmacotherapy & Translational Research/Post-doctoral

Fellow)

Authors: C Smith, S Ryan, J Moxley, L Thames, A Schentrup

# 12 Association of FTO with Hydrochlorothiazide-induced Elevation in Uric Acid in

African American Hypertensives in the Pharmacogenomic Evaluation of

Antihypertensive Response (PEAR) Study

Presenter: Alexander Vandell (Pharmacotherapy & Translational Research/Post-

doctoral Fellow)

Authors: A Vandell, C McDonough, T Langaee, B Burkley, Y Gong, S Turner, J

Gums, A Chapman, A Beitelshees, K Bailey, E Boerwinkle, R Cooper-

DeHoff, J Johnson

# 13 Comparison of Suboptimal Treatments Identified from Claims Data Alone with a

Medication Therapy Management Patient Interview

Presenter: Tsu-Hsuan Yang (Pharmaceutical Outcomes and Policy/Post-doctoral

Fellow)

Authors: T-H Yang, D Folmar, S Stevens, R Segal, A Wolf, P Sessions, J Lannigan

46


# 14 Non-synonymous SNPs in SELE, SELP, and SIGLEC12 Associated with

Cardiovascular (CV) Outcomes in the INternational VErapamil SR-Trandolapril

STudy GENEtic Substudy (INVEST-GENES)

Presenter: Caitrin McDonough (Pharmacotherapy & Translational Research/Post-

doctoral Fellow)

Authors: C McDonough, B Burkley, Y Gong, T Langaee, C Pepine, R Cooper-

DeHoff, J Johnson

# 15 Inhibitory Effect of Six Commonly used Herbal Extracts on CYP2C8 Enzyme

Activity

Presenter: Ahmed Albassam (Pharmacotherapy & Translational Research/Graduate

Student)

Authors: A Albassam, R Frye

# 16 Exploratory Pharmacokinetics-Pharmacodynamics (PK-PD) Target Attainment

Analysis of PA-824

Presenter: Aline Barth (Pharmaceutics/Graduate Student)

Authors: A Barth, R Singh, E Egelund, Z Ahmad, E Nuermberger, C Peloquin, H

Derendorf

# 17 Compound-21, an AT2R Agonist, as a Novel Drug Therapy for Pulmonary

Hypertension

Presenter: Erin Bruce (Pharmacodynamics/Graduate Student)

Authors: E Bruce, V Shenoy, A Rathinasabapathy, U Steckelings, T Unger, M

Raizada, C Sumners, M Katovich

# 18 A Novel Approach of Regenerative Medicine for the Treatment of Alpha 1

Antitrypsin Deficiency

Presenter: Mong-Jen Chen (Pharmaceutics/Graduate Student)

Authors: M-J Chen, Y Lu, T Hamazaki, H-Y Tsai, A Srivastava, V Chiodo, W

Hauswirth, N Terada, S Song

# 19 Cortisol Increases Activated Caspase-3 in Conductive Cells in the Fetal Heart

Presenter: Xiaodi Feng (Pharmacodynamics/Graduate Student)

Authors: X Feng, M Keller-Wood

# 20 Breath Testing to Assess Definitive Adherence to Oral and Vaginal Medications

Presenter: Daniel Gonzalez (Pharmaceutics/Graduate Student)

Authors: D Gonzalez, T Morey, S Wasdo, J Wishin, B Quinn, A van der Straten, M

Booth, H Derendorf, R Melker, D Dennis


# 21 Synthesis of an Enzyme-cleavable Macromolecular Prodrug of Valproic Acid for

Targeted Drug Delivery

Presenter: AM Hassan (Pharmaceutics/Graduate Student)

Authors: AM Hassan, V Rolle, G Hochhaus

# 22 Exploring the Effects of Ammi visnaga on Kidney Stone Prevention:

Pharmacokinetic Evaluation of Ammi visnaga Extract and Visnagin in Rats

Presenter: Karin Haug (Pharmaceutics/Graduate Student)

Authors: K Haug, B Weber, G Hochhaus, V Butterweck

# 23 Novel 5-HT2C Receptor Agonists Alter Reward Pathway GABA Release in Rats: A

Promising Alcoholism Pharmacotherapy

Presenter: James Kasper (Pharmacodynamics/Graduate Student)

Authors: J Kasper, Z Sun, R Booth, J Peris

# 24 Preclinical Antipsychotic Efficacy of Novel Phenylaminotetralin (PAT) Analogs

Acting at Serotonin 5-HT2 Receptors

Presenter: Krishnakanth Kondabolu (Medicinal Chemistry/Graduate Student)

Authors: K Kondabolu, D Morgan, R Sakhuja, R Booth

# 25 Conjugation Causes Low Bioavailability of Gamma-mangostin in Rats

Presenter: Li Li (Pharmaceutics/Graduate Student)

Authors: L Li, A-R Han, A Kinghorn, R Frye, H Derendorf, V Butterweck

# 26 Population Pharmacokinetic Modeling of Methylprednisolone and Prednisolone

after Multiple Oral Dosing in Health Subjects

Presenter: Li Li (Pharmaceutics/Graduate Student)

Authors: L Li, H Möllmann, J Barth, S Rohatagi, G Hochhaus, H Derendorf

# 27 Psychotropic Polypharmacy in Pediatric Patients with ADHD, 1999-006

Presenter: Xinyue Liu (Pharmaceutical Outcomes and Policy/Graduate Student)

Authors: X Liu, P Kubilis, A Winterstein

# 28 A Novel 5-HT2C agonist/5-HT2A Antagonist Attenuates the Increase in Voluntary

Ethanol Consumption Seen After a Period of Alcohol Deprivation in Rats

Presenter: Kaley MacFadyen (Pharmacodynamics/Graduate Student)

Authors: K MacFadyen, C Doyle, J Winegar, A George, J Kasper, M Kim, C Canal, R

Booth, J Peris

47


# 29 Polymorphisms in Both CYP3A5 and ABCB1 (MDRI/P-gp) are Risk Factors for

Adverse Events in Jordanian Pediatric Renal Transplant Patients on Tacrolimus

Presenter: Sherwin Sy (Pharmaceutics/Graduate Student)

Authors: S Sy, R Singh, S Shilbayeh, R Zmeili, D Conrado, H Derendorf

# 30 Modulation of Voluntary Alcohol Consumption by 5-HT2A/C Receptor Subtypes: A

Promising Target for Treating Alcoholism

Presenter: Rajiv Tikamdas (Pharmacodynamics/Graduate Student)

Authors: R Tikamdas, R Aramini, S Bisceglia, P Cogan, K Chen, J Kasper, M Kim, C

Canal, R Booth, J Peris

# 31 Pharmacokinetic/Pharmacodynamic Modeling of In Vitro Activity of Vertilmicin, A

Novel Aminoglycoside Against Three Bacterial Strains

Presenter: Luning Zhuang (Pharmaceutics/Graduate Student)

Authors: L Zhuang, S Sy, H Xia, A Barbour, R Singh, C Liu, H Derendorf

JUDGES

POSTER COMPETITION

Abdolreza Davoodi-Semiromi, PhD

Research Assistant Professor

Pharmacotherapy & Translational Research

College of Pharmacy

University of Florida

Eric Krause, PhD

Assistant Professor

Pharmacodynamics

College of Pharmacy


Larry Lesko, PhD

Professor

Center for Pharmacometrics & System

Pharmacology

College of Pharmacy


Michael Philbin, PharmD

Senior Clinical Science Manager

Abbott

Winter Garden, FL

Teresa Roane, PharmD

Clinical Assistant Professor


MTM Communication and Care Center

College of Pharmacy


Stephan Schmidt, PhD

Assistant Professor

Center for Pharmacometrics & System

Pharmacology

College of Pharmacy


ORAL COMPETITION

Maureen McKenzie, PhD

Chief Executive Officer

DENALI BioTechnologies, Inc.

Soldotna, AK

Maria Miralles, PhD

Senior Pharmaceutical Management Advisor

United States Agency International

Development (USAID)

Washington, DC

Robert Navarro, PhD

Clinical Professor

Pharmaceutical Outcomes and Policy

College of Pharmacy


Larry Lopez, PharmD

Emeritus Professor


College of Pharmacy



office of research and graduate studies stafffile.cop.ufl.edu/millard/annual_reports/ar1112.pdf ·...

Documents